<SEC-DOCUMENT>0001193125-16-554317.txt : 20160425
<SEC-HEADER>0001193125-16-554317.hdr.sgml : 20160425
<ACCEPTANCE-DATETIME>20160425170510
ACCESSION NUMBER:		0001193125-16-554317
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20160614
FILED AS OF DATE:		20160425
DATE AS OF CHANGE:		20160425
EFFECTIVENESS DATE:		20160425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO BIOSCIENCES INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		161589616

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d147794ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by
a party other than the Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to &#167;240.14a-12</TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>SANGAMO BIOSCIENCES, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which the transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which the transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of the transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>To Be Held June&nbsp;14, 2016 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>To the Stockholders of Sangamo BioSciences, Inc.:
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;) of Sangamo BioSciences,
Inc., a Delaware corporation (the &#147;Company,&#148; &#147;Sangamo&#148; or &#147;we&#148;), will be held on Tuesday, June&nbsp;14, 2016, at 9:00&nbsp;a.m. Pacific time at 501 Canal Boulevard, Richmond, California 94804, for the following
purposes, as more fully described in the Proxy Statement accompanying this Notice: </FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">1. To elect eight
(8)&nbsp;directors to serve on the Board of Directors for a one-year term ending at the Annual Meeting held in 2017 or until their successors are duly elected and qualified; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">2. To approve an amendment of the Company&#146;s Certificate of Incorporation and Bylaws to eliminate the provisions
prohibiting removal of directors without cause; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">3. To ratify the appointment of Ernst&nbsp;&amp; Young LLP as
the Company&#146;s independent registered public accounting firm for the year ending December&nbsp;31, 2016; and </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">4. To transact such other business as may properly come before the meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In accordance with rules established by the Securities and Exchange Commission, we are providing you access to our proxy materials over
the Internet. Accordingly, on or prior to May&nbsp;2, 2016, we will mail a Notice of Internet Availability of Proxy Materials (the &#147;Notice&#148;), to our stockholders. The Notice will describe how to access and review our proxy materials,
including our proxy statement and annual report on Form&nbsp;10-K. The Notice as well as the printed copy of proxy cards will also describe how you may submit your proxy on the Internet or by telephone. If you received a Notice by mail and would
like to receive a printed copy of our proxy materials, you should follow the instructions for requesting such materials included in the Notice. We will mail our registered stockholders a printed copy of all proxy materials </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on April&nbsp;19, 2016, are entitled to notice of and to vote at the Annual Meeting.
The stock transfer books of Sangamo will remain open between the record date and the date of the meeting. A list of stockholders entitled to vote at the Annual Meeting will be available for inspection at the executive offices of Sangamo. All
stockholders are cordially invited to attend the meeting in person. To attend the meeting you will need a form of photo identification. If your shares are held in street name, you will also need to bring proof of your ownership of our common stock,
such as your most recent brokerage statement. Whether or not you plan to attend the meeting, please vote as soon as possible. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sincerely,</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center">


<IMG SRC="g147794g46y86.jpg" ALT="LOGO">
 </P></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Edward O. Lanphier&nbsp;II</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>President and Chief Executive Officer</B></FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richmond, California </FONT></P>  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">April 25, 2016 </FONT></P>  <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important Notice Regarding the Availability of Proxy
Materials </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>For the Stockholder Meeting to be Held on June&nbsp;14, 2016: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Proxy Statement, Proxy Card and Annual Report on Form 10-K for 2015 are available at: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>www.edocumentview.com/sgmo </I></B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>YOUR VOTE IS VERY IMPORTANT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REGARDLESS OF THE NUMBER OF SHARES&nbsp;YOU OWN, PLEASE
READ THE ATTACHED PROXY STATEMENT CAREFULLY, COMPLETE, SIGN AND DATE THE ENCLOSED PROXY CARD AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE ENCLOSED ENVELOPE. PLEASE REFER TO THE &#147;VOTING BY MAIL, VIA THE INTERNET OR BY TELEPHONE&#148;
SECTION&nbsp;ON PAGE&nbsp;2 OF THE PROXY STATEMENT FOR ALTERNATE VOTING METHODS. </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>501 Canal Boulevard </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Richmond, California 94804 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FOR THE ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>To Be Held On June&nbsp;14, 2016 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The enclosed proxy card (&#147;Proxy&#148;) is solicited on behalf of the Board of Directors of Sangamo BioSciences, Inc., a Delaware
corporation (the &#147;Company&#148;, &#147;Sangamo&#148; or &#147;we&#148;), for use at the Annual Meeting of Stockholders to be held on Tuesday, June&nbsp;14, 2016 (the &#147;Annual Meeting&#148;). The Annual Meeting will be held at 9:00&nbsp;a.m.
Pacific time at 501&nbsp;Canal Boulevard, Richmond, California 94804. We expect to commence the mailing of notices of the Annual Meeting to our stockholders on or about May 2, 2016. </FONT></P>  <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Voting </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The specific proposals to be considered and acted upon at the
Annual Meeting are summarized in the accompanying notice of Annual Meeting (the &#147;Notice&#148;) and are described in more detail in this Proxy Statement (the &#147; Proxy Statement&#148;). On April 19, 2016, the record date for determination of
stockholders entitled to notice of and to vote at the Annual Meeting, 70,400,832 shares of Sangamo&#146;s common stock, par value $0.01, were issued and outstanding. No shares of Sangamo&#146;s preferred stock, par value $0.01, were outstanding.
Each stockholder is entitled to one vote for each share of common stock held by such stockholder on the record date. Stockholders may not cumulate votes in the election of directors. All votes will be tabulated by the Inspector of Election appointed
for the Annual Meeting, who will separately tabulate affirmative and negative votes, abstentions and broker non-votes. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Quorum and Broker Non-Votes </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Holders of majority in number of the outstanding and issued shares of our common stock entitled to vote at the Annual Meeting on the record date must be present in person or represented by proxy at the
Annual Meeting in order to have a quorum. Abstentions and broker non-votes will be treated as shares present for the purpose of determining the presence of a quorum for the transaction of business at the Annual Meeting. If the persons present or
represented by proxy at the Annual Meeting constitute the holders of less than majority&nbsp;of the outstanding and issued shares of our common stock as of the record date, the Annual Meeting may be adjourned without stockholder vote to a subsequent
date for the purpose of obtaining a quorum. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Broker non-votes result from shares held of record by stock brokerage firms or
financial institutions which are not voted due to the failure of the beneficial owners of those shares to provide voting instructions as to certain non-routine matters as to which such brokerage firms or financial institutions are not permitted to
vote on a discretionary basis. Two matters to be submitted to stockholder approval at the Annual Meeting, the amendment of our Certificate of Incorporation (Proposal No.&nbsp;2) and the ratification of the appointment of Ernst&nbsp;&amp; Young LLP
(Proposal&nbsp;No.&nbsp;3), are considered a &#147;routine matter&#148; and therefore brokerage firms or other financial institutions will not be precluded from voting in the absence of voting instructions from the beneficial owners of the share,
and therefore no broker non-votes exist for this proposal. Proposal No.&nbsp;1, or the election of directors, is considered a &#147;non-routine matter,&#148; therefore broker non-votes may occur if the beneficial owners do not provide voting
instructions to the brokerage firms or other financial institutions. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Votes Required for Each Proposal </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The required vote for each of the proposals expected to be acted upon at the Annual Meeting is described below: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Proposal&nbsp;No.&nbsp;1 &#151; Election of directors.</I>&nbsp;Each director will be elected by the majority of votes cast with
respect to such director. Our Second Amended and Restated Bylaws (the &#147;Bylaws&#148;) provides that any incumbent director who does not receive the required majority votes at the Annual Meeting will promptly tender his or her resignation to the
Board, and the Board, after considering the recommendation of the Nomination and Corporate Governance Committee regarding such resignation, shall determine whether to accept or reject the resignation. For a more detailed description of the majority
voting process, see <I>Proposal No.&nbsp;1: Election of Directors &#151;General </I>below. Abstention and broker non-votes will have no effect in Proposal No.&nbsp;1. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Proposal&nbsp;No.&nbsp;2 &#151; To approve an amendment of the Company&#146;s Certificate of Incorporation and Bylaws to eliminate the provisions prohibiting removal of directors without cause.</I> The
affirmative vote of a majority of the shares of our common stock outstanding and entitled to vote at the Annual Meeting is required to approve Proposal No.&nbsp;2. As a result, abstentions will have the same effect as voting against the proposal. We
do not expect broker non-votes in Proposal No.&nbsp;2. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Proposal&nbsp;No.&nbsp;3 &#151; Ratification of independent
registered public accounting firm.</I>&nbsp;This proposal must be approved by a majority of the shares present in person or represented by proxy and entitled to vote on the proposal. As a result, abstentions will have the same effect as voting
against the proposal. We do not expect broker non-votes in Proposal No.&nbsp;3. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendations of the Board of Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After careful consideration, our Board of Directors has unanimously approved the proposals described in this Proxy Statement and their
recommendations for each proposal are set forth below: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:30pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Proposal</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:147pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Recommendation&nbsp;of&nbsp;the&nbsp;Board&nbsp;of&nbsp;Directors</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1&nbsp;&nbsp;Election of Directors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;FOR all Nominees</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2&nbsp;&nbsp;To approve an amendment of the Company&#146;s Certificate of Incorporation and Bylaws</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;FOR</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3&nbsp;&nbsp;Ratification of the appointment of Ernst &amp; Young LLP as our independent registered accounting firm for the year
ending December 31, 2016</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;FOR</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting by Mail, via the Internet or by Telephone </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may vote by mailing a completed proxy card, by telephone or over the Internet. Should you receive more than one proxy card because
your shares are registered in different names and addresses, each Proxy should be signed and returned or the shares represented thereby should be voted by telephone or over the Internet to assure that all your shares will be voted. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Registered Holders </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If your shares are registered in your own name as a registered holder, you may vote by mailing a completed proxy card, via the Internet or by telephone. Instructions for voting via the Internet or by
telephone are set forth in the proxy card attached to this Proxy Statement. To vote by mailing a proxy card, sign and return the enclosed proxy card in the enclosed prepaid and addressed envelope and your shares will be voted at the Annual Meeting
in the manner you direct. In the event no directions are specified, the proxy holders will vote your shares in the manner recommended by our Board of Directors on all matters presented in this Proxy Statement and as the proxy holders may determine
in their discretion with respect to any other matters properly presented for a vote at the Annual Meeting. If you are a registered holder and you do not return the proxy card, your shares will not be
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
voted and will not be deemed present for the purpose of determining whether a quorum exists. You may revoke or change your proxy vote at any time before the Annual Meeting by sending a written
notice of revocation or submitting another proxy with a later date to the Inspector of Elections of the Company at the Company&#146;s principal executive offices before the beginning of the Annual Meeting. You may also revoke your proxy vote by
attending the Annual Meeting and voting in person. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owners </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are registered in the name of a bank or brokerage firm, you may be eligible to vote your shares over the Internet or by
telephone rather than by mailing a completed voting instruction card provided by the bank or brokerage firm. Please check the voting instructions card provided by your bank or brokerage firm for availability and instructions. If Internet or
telephone voting is unavailable from your bank or brokerage firm, please complete and return the enclosed voting instruction card in the self-addressed postage paid envelope provided. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Solicitation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo will bear the entire cost of solicitation, including
the preparation, assembly, printing and mailing of this Proxy Statement and any additional solicitation materials furnished to the stockholders. Copies of solicitation materials will be furnished to brokerage firms, fiduciaries and custodians
holding shares in their names that are beneficially owned by others so that they may forward this solicitation material to such beneficial owners. In addition, Sangamo may reimburse such persons for their costs in forwarding the solicitation
materials to such beneficial owners. The original solicitation of proxies by mail may be supplemented by a solicitation by telephone, facsimile or other means by directors, officers, employees or agents of Sangamo. No additional compensation will be
paid to these individuals for any such services. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Deadline for Receipt of Stockholder Proposals </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposals of stockholders of Sangamo that are intended to be presented by such stockholders at Sangamo&#146;s Annual Meeting in 2017 must
be received no later than January&nbsp;2, 2017, in order that they may be included in the Proxy Statement and form of Proxy relating to that meeting. In addition, the Proxy solicited by the Board of Directors for the Annual Meeting in 2017 will
confer discretionary authority to vote on any stockholder proposal presented at that meeting, if Sangamo does not receive notice of such proposal prior to March&nbsp;16, 2017. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MATTERS TO BE CONSIDERED AT THE ANNUAL MEETING </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;NO. 1: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the Annual Meeting, eight (8)&nbsp;directors are to be elected to serve until the next Annual Meeting of Stockholders or until a
successor for such director is duly elected and qualified, or until the death, resignation or removal of such director. The nominees for election have agreed to serve if elected, and management has no reason to believe that such nominees will be
unavailable to serve. In the event the nominees are unable or decline to serve as directors at the time of the Annual Meeting, the proxies will be voted for any nominee who may be designated by the present Board of Directors to fill the vacancy.
Unless otherwise instructed, the proxy holders will vote the proxies received by them FOR the nominees named below. Our current director, John W. Larson, will not stand for reelection at the Annual Meeting. Mr.&nbsp;Robert&nbsp;F. Carey is a new
director nominee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the eight (8)&nbsp;nominees set forth in this Proxy Statement will be elected by the majority of
the votes cast with respect to such nominee. If an incumbent director does not receive the required majority vote, the director shall promptly tender his or her resignation to the Board. Within ninety (90)&nbsp;days after the Annual Meeting, the
Nominating and Corporate Governance Committee will make a recommendation to the Board of Directors as to whether to accept or reject the resignation. The Board will act by taking into account such committee&#146;s recommendation. If the Board does
not accept the resignation, the Board is required to publicly disclose its decision and the rationale behind the decision. For more details about the majority voting standard, see our Bylaws that were filed as an exhibit to the Company&#146;s Form
8-K filed on June&nbsp;19, 2014. </FONT></P>  <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nominees for Term Ending Upon the Annual Meeting of Stockholders in 2017 </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Edward O. Lanphier&nbsp;II</I>, age&nbsp;59, the founder of Sangamo BioSciences, Inc., has served as our President, Chief Executive
Officer and as a member of our Board of Directors since Sangamo&#146;s inception in 1995. Mr.&nbsp;Lanphier has over 30 years of experience in the pharmaceutical and biotechnology industry. From June 1992 to May 1997, he held various positions at
Somatix Therapy Corporation, a gene therapy company, including Executive Vice President, Commercial Development and Chief Financial Officer. Prior to Somatix, Mr.&nbsp;Lanphier was President and Chief Executive Officer of BioGrowth, Inc., a
biotechnology company that merged with Celtrix Laboratories to form&nbsp;Celtrix Pharmaceuticals, Inc. in 1991. From 1986 to 1987, Mr.&nbsp;Lanphier served as Vice President of Corporate Development at Biotherapeutics, Inc. From 1984 to 1986, he
served as Vice President of Corporate Development at Synergen Inc. Prior to Synergen, he was employed by Eli&nbsp;Lilly and Company, a pharmaceutical company, in the strategic business planning biotechnology group. He currently serves on the board
of directors of the Biotechnology Institute, the board of directors and as Chairman of the Alliance for Regenerative Medicine, the board of trustees for The Buck Institute for Research on Aging and the Dean&#146;s Advisory Board of the University of
Michigan School of Public Health. Mr.&nbsp;Lanphier received a B.A. in biochemistry from Knox College. Mr.&nbsp;Lanphier brings extensive experience in executive management of biotechnology companies focused on the therapeutic development of
biologics. In addition, Mr.&nbsp;Lanphier&#146;s day-to-day leadership and intimate knowledge of Sangamo&#146;s business and operations, as well as Sangamo&#146;s relationships with partners, collaborators and investors, provide the Board with an
in-depth understanding of the Company. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Robert F. Carey</I>, age 57, is a new director nominee. Mr. Carey has been
executive vice president, chief business officer for Horizon Pharma plc, a biopharmaceutical company, since March 2014. Prior to that, he served as managing director and head of the healthcare investment banking group at JMP Securities LLC from
March 2003 to March 2014. Prior to JMP, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities International, Inc. He has also held roles at Shearson Lehman Hutton and Ernst &amp; Whinney.
Mr. Carey has served on the board of directors of Argos Therapeutics, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Inc., a life science company, since September 2015. Mr. Carey received his B.S. in accounting from the University of Notre Dame. Mr. Carey&#146;s extensive experience in, and knowledge of, the
healthcare investment banking industry, particularly with regards to financings and strategic transactions involving life science companies, as well as his role as a senior executive leading the business development efforts for a public, commercial
biopharmaceutical company, will provide the Board with valuable insight and contribution. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Paul B. Cleveland</I>,
age&nbsp;59, has served as a member of our Board of Directors since November 2008. Since November 2015 Mr.&nbsp;Cleveland has served as President, CEO and a member of the board of directors of Avalanche Biotechnologies, Inc. From June 2015 to
November 2015, he was President, CEO and a member of the board of directors of Celladon Corporation, an AAV cardiovascular gene therapy company. From June 2014 to June 2015, he was President and CFO of Celladon Corporation. From February 2013 to
August 2013, he was Executive Vice President, Corporate Strategy and Chief Financial Officer of Aragon Pharmaceuticals, a private biotechnology company focused on the development of small-molecule drugs for the treatment of hormone-dependent
cancers. From April 2011 through February 2013, he served as General Partner and Chief Operating Officer of Mohr Davidow Ventures. From January 2006 through February 2011, Mr.&nbsp;Cleveland served as Executive Vice President, Corporate Development
and Chief Financial Officer of Affymax, Inc., a biopharmaceutical company. From April 2004 to December 2005, he served as a Managing Director at Integrated Finance, Ltd., an investment bank. From September 1996 to April 2003, he served as a Managing
Director at J.P.&nbsp;Morgan Chase and Co. (and a predecessor firm, Hambrecht&nbsp;&amp; Quist), an investment bank. From January 1993 to September 1996, he was a partner at Cooley Godward LLP, a law firm. From December 1988 to December 1992, he was
a corporate attorney at Sidley Austin LLP, a law firm, and from September 1981 to November 1988, he was a corporate attorney at Davis Polk&nbsp;&amp; Wardwell, a law firm. Mr.&nbsp;Cleveland received a J.D. from Northwestern University School of Law
and an A.B. from Washington University in St. Louis. Mr.&nbsp;Cleveland brings extensive experience in the areas of finance, investment banking and corporate and securities law to our Board. His experience as the President and Chief Executive
Officer and as Chief Financial Officer of several biotechnology companies also provides additional insight to the Board on the operational, financial issues and best practices of such companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stephen G. Dilly, M.B.B.S., Ph.D.,</I> age 56, has served as a member of our Board of Directors since March 2010. Since May 2014
Dr.&nbsp;Dilly has served as Chief Executive Officer and a member of the board of directors of Aimmune Therapeutics, Inc. (formerly Allergen Research Corporation), a biotechnology company developing treatments for food allergies. From January 2012
to December 2012, he was Chief Executive Officer of PhotoThera, Inc., a medical device company. From 2006 to December 2011, he served as President and Chief Executive Officer and a member of the board of directors of APT Pharmaceuticals, Inc., a
drug development company.&nbsp;From 2007 to 2009, he served as a member of the board of directors of Avigen, Inc., a biopharmaceutical company which merged with MediciNova, Inc. in December 2009. From 2003 to 2006, he served as Chief Medical Officer
and Senior Vice President of Development of Chiron BioPharma, a biotechnology company which was later acquired by Novartis International AG. From 1998 to 2003, he held various management positions at Genentech, Inc., including Vice President of
Development Sciences from 2002 to 2003 and Vice President of Medical Affairs from 1998 to 2001. From 1988 to 1998, Dr.&nbsp;Dilly held various management positions in drug development with SmithKline Beecham in the U.K. During his career,
Dr.&nbsp;Dilly has been closely associated with the development and launch of marketed drugs for many therapeutic areas, including Kytril, Paxil, Kredex, Requip, TNKase, Xolair, Avastin, Raptiva, Tarceva, Lucentis and Cubicin. In 1982 Dr.&nbsp;Dilly
received an M.B.B.S., the equivalent of an M.D. in the U.S., from the University of London in the U.K. and a Ph.D. in cardiac physiology from University of London in 1988. Dr.&nbsp;Dilly brings medical expertise and significant drug development
experience to our Board. Dr.&nbsp;Dilly&#146;s extensive experience in all stages of drug development, from project prioritization through clinical trial design and data analysis to product launch, provides the Board with valuable insight into this
process as the Company continues to advance and develop our ZFP Therapeutic pipeline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Steven J. Mento,&nbsp;Ph.D.,</I>
age&nbsp;64, has served as a member of our Board of Directors since May 2005. Since July 2005 Dr.&nbsp;Mento has served as President and Chief Executive Officer of Conatus Pharmaceuticals Inc., a biotechnology company engaged in the development of
human therapy for liver disease. From 1997 to 2005, he </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
was President and Chief Executive Officer of Idun Pharmaceuticals. From 1992 to 1997, Dr.&nbsp;Mento was an executive officer at Viagene, Inc. In January of 1992 he joined Viagene, Inc. as Vice
President of Research and Development, where he was responsible for directing the company&#146;s transition from basic research through initiation of the first company sponsored Phase&nbsp;I and Phase&nbsp;II clinical trials in the emerging field of
gene therapy. In October of 1995, Chiron Corporation acquired Viagene, Inc., and renamed the company Chiron Viagene, Inc. Prior to that, from 1982 to 1992, Dr.&nbsp;Mento held various positions at American Cyanamid Company, the last one being the
Director of Viral Vaccine Research and Development at Lederle-Praxis Biologicals, a business unit of American Cyanamid Company. Dr.&nbsp;Mento currently serves on the boards of BIOCOM, the BIOCOM Institute and the Biotechnology Industry Organization
(BIO), as well as a member of the BIO ECS Governing Body, the BIO Health Section Governing Body, the Donald P. Shiley BioScience Center at SDSU Scientific Advisory Board and Cal&nbsp;State San&nbsp;Marcos Advisory Council. Dr.&nbsp;Mento received a
B.A., M.S., and a Ph.D. in microbiology from Rutgers University. He completed his post-doctoral fellowship in somatic cell genetics at the University of Toronto. Dr.&nbsp;Mento&#146;s technical background and extensive operational experience in the
early stages of the development of biologic drugs provide the Board with expertise in the management and development of our novel ZFP Therapeutic platform. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>H. Stewart Parker, age 60</I>, has been a member of our Board of Directors since June 2014. Ms.&nbsp;Parker has over 30 years of experience in the biotechnology industry. She served as the Chief
Executive Officer of The Infectious Disease Research Institute (IDRI), a not-for-profit global health Research institute from March 2011 to December 2013. In 1992 Ms.&nbsp;Parker founded Targeted Genetics Corporation, a publicly traded Seattle-based
biopharmaceutical company formed to develop gene-based treatments for acquired and inherited diseases that became a world leader in AAV gene therapy. She held the position of President and Chief Executive Officer and was a member of its board of
directors from the company&#146;s inception until November 2008. Prior to founding Targeted Genetics, Ms.&nbsp;Parker served in various capacities at Immunex from August 1981 through December 1991, most recently as Vice President, Corporate
Development. From February 1991 to January 1993, Ms.&nbsp;Parker served as President and a Director of Receptech Corporation, a company formed by Immunex in 1989 to accelerate the development of soluble cytokine receptor products. She has served on
the board of directors and the executive committee of BIO, the primary trade organization for the biotechnology industry. She currently serves as a member of the board of directors for several for-profit companies including C3 Jian Inc, Oncogenex
Technologies Inc. and Nexgenia and on the advisory boards of the University of Washington Foundation and College of Arts&nbsp;&amp; Sciences. Ms.&nbsp;Parker received her B.A. and M.B.A. from the University of Washington. Ms.&nbsp;Parker&#146;s
senior executive experience in AAV gene therapy and biotechnology drug development provides valuable operational, commercial assessment and management skills to the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Saira Ramasastry</I>, age 40, has served as a member of our Board of Directors since June 2012. Since April 2009 she has served as Managing Partner of Life Sciences Advisory, LLC, a company that she
founded to provide strategic advice, business development solutions and innovative financing strategies for the life science industry. From August 1999 to March 2009, Ms.&nbsp;Ramasastry was an investment banker with Merrill Lynch&nbsp;&amp; Co.,
Inc. where she helped establish the biotechnology practice and was responsible for origination of mergers and acquisitions (M&amp;A), strategic and capital markets transactions. Prior to joining Merrill Lynch she served as a financial analyst in the
M&amp;A group at Wasserstein Perella&nbsp;&amp; Co., an investment banking firm, from July 1997 to September 1998. Ms.&nbsp;Ramasastry currently serves on the Industry Advisory Board of the Michael J. Fox Foundation for Parkinson&#146;s Research,
the board of directors of Pain Therapeutics, Inc. and lead business advisor for the European Prevention of Alzheimer&#146;s Dementia (&#147;EPAD&#148;) consortium. Ms.&nbsp;Ramasastry received her B.A. in economics with honors and distinction and an
M.S. in management science and engineering from Stanford University, as well as an M. Phil. in management studies from the University of Cambridge where she is a guest lecturer for the Bioscience Enterprise Programme and serves on the Cambridge
Judge Business School Advisory Council. Ms.&nbsp;Ramasastry&#146;s extensive experience in global healthcare investment banking and strategic advisory consulting provides valuable financial, commercial assessment and business development skills to
the Board and her thorough understanding of the Company&#146;s technology and programs provides the Board with valuable insight in the development of our novel ZFP Therapeutic platform. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>William R. Ringo,</I> age 70, has served as Chairman of our Board of Directors since
April 2010. From April 2008 until his retirement in April 2010, Mr.&nbsp;Ringo was Senior Vice President of Business Development, Strategy and Innovation at Pfizer Inc. and was responsible for guiding Pfizer&#146;s overall strategic planning and
business development activities. Prior to joining Pfizer, he served as an executive in residence at Warburg Pincus and Sofinnova Ventures. From August 2004 to April 2006, Mr.&nbsp;Ringo was President and Chief Executive Officer of Abgenix, Inc., a
biotechnology firm focused on developing human antibodies as agents to treat cancer and other serious diseases. At Abgenix, he led efforts to transform the organization into a more focused product company by strengthening the senior management team
and enhancing an existing partnership with Amgen, which acquired Abgenix in 2006. Mr.&nbsp;Ringo began his career at Eli Lilly&nbsp;&amp; Company in 1973 and during his 28-year tenure he held a number of senior positions, including Product Group
President for Oncology and Critical Care, President of Internal Medicine Products, President of the Infectious Diseases Business Unit and Vice President of Sales and Marketing for U.S. Pharmaceuticals. He retired from Lilly in 2001. From 2001 to
2007, he served on various boards of directors, including Encysive Pharmaceuticals, Inc., Inspire Pharmaceuticals, Inc. and InterMune, Inc. where he was the non-executive chairman of the board of directors after serving as interim Chief Executive
Officer from June to September 2003. Mr.&nbsp;Ringo served on the board of directors of Onyx Pharmaceuticals, Inc. from 2011 to 2013. He also serves on the board of directors of BioCrossroads, a public-private collaboration of corporate, university,
government and entrepreneurial leaders that supports Indiana&#146;s life sciences research and corporate strengths in life sciences while encouraging business development in the region. Mr.&nbsp;Ringo currently serves on the board of directors of
Assembly Biosciences, Inc., Immune Design, Dermira, Inc., Five Prime Therapeutics and Mirati Therapeutics. He received a B.S. in business administration and an M.B.A. from the University of Dayton. Mr.&nbsp;Ringo&#146;s extensive senior executive
experience in both biotechnology and pharmaceutical companies provides valuable operational, commercial assessment, corporate leadership and management skills to the Board. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Other Current Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>John W. Larson</I><B></B>, age 80, has
served as a member of our Board of Directors since January 1996. From February 2003 to December 2009, Mr.&nbsp;Larson served as a partner at the law firm of Morgan, Lewis&nbsp;&amp; Bockius LLP. From 1969 to January 2003, Mr.&nbsp;Larson served as
partner at the law firm of Brobeck, Phleger&nbsp;&amp; Harrison LLP, except for the period from July 1971 to September 1973 when he was in government service as Assistant Secretary of the United States Department of the Interior and Counselor to
George P. Shultz, Chairman of the Cost of Living Council. From 1988 until March 1996, Mr.&nbsp;Larson was Chief Executive Officer of Brobeck. Mr.&nbsp;Larson serves on the boards of directors of Needham Funds and WageWorks, Inc. and other
organizations. Mr.&nbsp;Larson received a L.L.B. and a B.A., with distinction, in economics, from Stanford University. Mr.&nbsp;Larson&#146;s extensive legal career and business background and his experience on the boards of numerous public and
private companies provides the Board with substantial expertise in corporate governance and risk management, securities law and corporate finance transactions<B> </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Board Independence </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has determined that each of its
current and nominated directors is independent under applicable listing standard of NASDAQ Stock Market LLC (&#147;NASDAQ&#148;), except for Mr.&nbsp;Lanphier, who is the Chief Executive Officer of the Company. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Committees and Meetings </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors held six meetings and acted twice by unanimous written consents in lieu of a meeting during 2015. The Board of Directors has an Audit Committee, a Compensation Committee, a
Nominating and Corporate Governance Committee and a Clinical Review Committee. Each director attended or participated in 75% or more of the aggregate of (i)&nbsp;the total number of meetings of the Board of Directors and (ii)&nbsp;the total number
of meetings held by all committees of the Board on which such director served during 2015. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Audit Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee currently consists of three directors: Mr.&nbsp;Cleveland, Ms.&nbsp;Parker and Ms.&nbsp;Ramasastry. In June 2015 Ms.&nbsp;Parker was appointed to serve on the Audit Committee and she
replaced Dr.&nbsp;Dilly and Dr.&nbsp;Mento, who served as members of the Audit Committee prior to her appointment. Our Board of Directors has determined that each member of the Audit Committee is independent under the applicable listing standard of
NASDAQ and Securities and Exchange Commission (&#147;SEC&#148;) rules. Mr.&nbsp;Cleveland serves as the Chairman of this committee. The Board of Directors has determined that Mr.&nbsp;Cleveland is an &#147;audit committee financial expert&#148; as
defined under SEC rules and has the requisite financial sophistication in accordance with the applicable NASDAQ listing standards. The Audit Committee held five meetings during 2015. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee assists the Board of Directors in its oversight of the integrity of the Company&#146;s financial statements, the risk
management and internal controls of the Company and the Company&#146;s compliance with legal and regulatory requirements. The Audit Committee interacts directly with, and evaluates the performance of, the independent registered public accounting
firm, including determining whether to engage or dismiss the independent registered public accounting firm and to monitor the independent registered public accounting firm&#146;s qualifications and independence. The Audit Committee also pre-approves
all audit services and permissible non-audit services provided by the independent registered public accounting firm. The Audit Committee Report is included herein on page 46. The Audit Committee has a written charter which is available on our
website at www.sangamo.com. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee currently consists of three directors: Dr.&nbsp;Mento, Mr.&nbsp;Larson and Mr.&nbsp;Ringo, each of whom is independent under applicable listing standard of NASDAQ and SEC rules.
Dr.&nbsp;Mento serves as the Chairman of this committee. Following the Annual Meeting, the Compensation Committee will consist of Dr.&nbsp;Mento, Ms.&nbsp;Parker and Mr.&nbsp;Ringo. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee&#146;s responsibilities include (i)&nbsp;establishing, administering and reviewing compensation plans and
programs for the Company&#146;s executive officers and other employees, including incentive and equity-based plans and programs; (ii)&nbsp;establishing compensation arrangements for the executive officers and setting the performance goals for their
incentive compensation programs; (iii)&nbsp;evaluating the performance of executive officers and awarding incentive compensation; (iv)&nbsp;adjusting compensation arrangements as appropriate based upon performance; and (v)&nbsp;reviewing and
monitoring management development and succession plans and activities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee is authorized to engage,
oversee and terminate independent compensation consultants and other professionals to assist in the design, formulation, analysis and implementation of compensation programs for the Company&#146;s executive officers and other key employees. The
Compensation Committee retained the services of Radford, an Aon Hewitt Company (&#147;Radford&#148;), in order to (i)&nbsp;assess compensation levels and mix of elements for the Company&#146;s executive officers and vice presidents for 2015,
(ii)&nbsp;review the peer group companies selected in 2014 and recommend any changes to that list, and (iii)&nbsp;advise the committee on executive compensation and governance trends based on peer group trends and market practices. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee held six meetings and acted by unanimous written consent in lieu of a meeting two times during 2015. The
Compensation Committee has a written charter, which is available on our website at www.sangamo.com. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee Interlocks and
Insider Participation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of our Compensation Committee members has been an officer or employee of Sangamo at any time.
None of our executive officers serves on the board of directors or compensation committee of any entity that has one or more executive officers serving as a member of our Board or our Compensation Committee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nominating and Corporate Governance Committee </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee currently consists of three directors: Mr.&nbsp;Larson, Mr.&nbsp;Cleveland and
Mr.&nbsp;Ringo, each of whom is independent under applicable listing standard of NASDAQ. Mr.&nbsp;Larson serves as the Chairman of this committee. The Nominating and Corporate Governance Committee considers and periodically reports on matters
relating to the size, identification, selection and qualification of the Board of Directors and candidates nominated for the Board of Directors and its committees, and develops and recommends governance principles and policies applicable to the
Company. Immediately following the Annual Meeting, the Nominating and Corporate Governance Committee will consist of Mr.&nbsp;Cleveland and Mr.&nbsp;Ringo. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee acted once by unanimous written consent in lieu of a meeting during 2015. The Nominating and Corporate Governance Committee has a written charter which is
available on our website at www.sangamo.com. The Nominating and Corporate Governance Committee considers properly submitted stockholder recommendations for candidates for membership on the Board of Directors as described below under
&#147;Identification and Evaluation of Nominees for Directors.&#148; In evaluating such recommendations, the Nominating and Corporate Governance Committee seeks to achieve a balance of knowledge, experience and capability on the Board of Directors
and to address the membership criteria set forth under &#147;Director Qualifications.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Director Qualifications </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee will use a variety of criteria to evaluate the qualifications and skills necessary for
members of our Board of Directors. The Nominating and Corporate Governance Committee may assess character, judgment, business acumen and scientific expertise, and familiarity with issues affecting the biotechnology and pharmaceutical industries.
Other qualifications will be determined on a case-by-case basis, depending on whether the Nominating and Corporate Governance Committee desires to fill a vacant seat or increase the size of the Board to add new directors. In addition, the Nominating
and Corporate Governance Committee may also evaluate whether a potential director nominee&#146;s skills are complementary to existing Board members&#146; skills or meet the Board&#146;s need for operations, management, commercial, financial or other
expertise. While the Nominating and Corporate Governance Committee does not prescribe specific diversity standards, as a matter of practice, the committee considers diversity in the context of the Board as a whole and takes into account the personal
characteristics and experiences of current and prospective directors that reflect a broad range of perspectives in the Board&#146;s decision making process. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Identification and Evaluation of Nominees for Directors </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and
Corporate Governance Committee utilizes a variety of methods for identifying and evaluating nominees for director. The Nominating and Corporate Governance Committee assesses the appropriate size of the Board of Directors, and whether any vacancies
on the Board of Directors are expected due to retirement or otherwise. In the event that vacancies are anticipated, or otherwise arise, the Nominating and Corporate Governance Committee considers various potential candidates for director. Candidates
may come to the attention of the Nominating and Corporate Governance Committee through current members of the Board of Directors or senior management, executive recruiting firms, stockholders or other persons. These candidates are evaluated at
regular or special meetings of the Nominating and Corporate Governance Committee, and may be considered at any point during the year. The Nominating and Corporate Governance Committee considers properly submitted stockholder recommendations for
candidates for the Board of Directors. Stockholder nominees will receive the same consideration that nominees of the Board receive. Any stockholder recommendations proposed for consideration by the Nominating and Corporate Governance Committee must
provide all information requested by the Nominating and Corporate Governance Committee relating to such recommendation, including the candidate&#146;s name and qualifications for membership on the Board of Directors and should be addressed to
Investor Relations at the following address: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investor Relations Department </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo BioSciences, Inc. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">501 Canal Boulevard </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richmond, CA 94804 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In evaluating such recommendations, the Nominating and Corporate Governance Committee
applies the qualifications standards discussed above and seeks to achieve a balance of knowledge, experience and capability on the Board of Directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Clinical Review Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Clinical Review Committee was established in
September 2010 for the purpose of overseeing the ongoing and proposed human clinical trials of the Company. The Clinical Review Committee meets from time to time and its responsibilities include monitoring patient recruitment, clinical monitoring,
data analysis, clinical data distribution and the review of study protocols. The Clinical Review Committee currently consists of three directors: Dr.&nbsp;Dilly, Dr.&nbsp;Mento and Mr.&nbsp;Lanphier. Dr.&nbsp;Dilly serves as the Chairman of this
committee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Leadership Structure of the Board </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under our Bylaws, the Board is not required to appoint our Chief Executive Officer as the Chairman of the Board, and the Board does not have a policy on whether or not the roles of Chief Executive Officer
and Chairman of the Board should be separate. Currently two individuals serve these two positions. Mr.&nbsp;William Ringo serves as the Chairman of the Board. On March&nbsp;16, 2016, based on the recommendation of the Nominating and Corporate
Governance Committee, the Board approved a resolution to combine the positions of Chief Executive Officer and Chairman of the Board and appointed Mr.&nbsp;Lanphier as the Chairman of the Board, effective immediately following the Annual Meeting.
Mr.&nbsp;Lanphier has extensive knowledge and experience in the life science industry and an in-depth understanding of our business strategies and day-to-day operations, which makes him well suited to set the agenda and lead the discussions at board
meetings as the Chairman.&nbsp;This will also facilitate communications between the Board and management by ensuring a regular flow of information, thereby enhancing the Board&#146;s ability to make informed decisions on critical issues facing our
company. As a result of combining the two positions and to ensure the independent oversight of the management by the Board, the Board also appointed H. Stewart Parker as a lead independent director of the Board, effective immediately following the
Annual Meeting. The authority and responsibilities of the lead independent director include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">presiding over all executive sessions of independent directors, with the authority to call such other meetings of the independent directors as she
deems necessary </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">presiding at meetings of the Board in the absence of the Chairman of the Board; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing and approving the scheduling of Board meetings, as well as agenda and materials for each Board meeting and executive session of the
Board&#146;s independent directors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">serving as a liaison and supplemental channel of communication between independent directors and the Chairman and Chief Executive Officer;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">communicating with stockholders of the Company if requested by major stockholders </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approving and coordinating the retention of advisors and consultants who report directly to independent directors. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Of the eight directors on our board following the Annual Meeting, seven directors are independent under applicable NASDAQ corporate
governance rules. The Board believes that this establishes a strong independent board that provides effective oversight of the Company. Moreover, in addition to feedback provided during the course of Board meetings, the independent directors conduct
regular executive sessions without the presence of Mr.&nbsp;Lanphier or any other members of management. We believe that our leadership structure of the Board, particularly with the appointment of a strong lead independent director with substantial
authorities and responsibilities, is appropriate given the nature and size our businesses, because it provides both effective independent oversight and expertise in the complexity and management of our operations as a life sciences company.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Oversight of Risk Management by the Board </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors is generally responsible for the oversight of corporate risk in its review and deliberations relating to Company
activities and has determined that the Company&#146;s principal source of risk falls into two categories, financial and product development and testing. The Audit Committee oversees management of financial risks. Our Board of Directors regularly
reviews information regarding the Company&#146;s cash position, liquidity and operations, as well as the risks associated with each. The Board regularly reviews plans, results and potential risks related to our lead therapeutic development programs
and other preclinical programs as well as financial and strategic risk related to our Company&#146;s operations. In addition, the Board of Directors established the Clinical Review Committee in September 2010, which is responsible for, among other
things, monitoring and reviewing risks associated with conducting clinical trials for our human therapeutic programs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
addition, the Nominating and Corporate Governance Committee monitors the effectiveness of our corporate governance guidelines and policies and manages risks associated with the independence of the Board of Directors and potential conflicts of
interest. Our Compensation Committee oversees risk management as it relates to our compensation plans, policies and practices for all employees, including executives, particularly whether our compensation programs may create incentives for our
employees to take excessive or inappropriate risks which could have a material adverse effect on the Company. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire Board of Directors
is regularly informed through committee reports about such risks. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Annual Meeting Attendance </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we do not have a formal policy regarding attendance by members of the Board of Directors at our annual meetings of stockholders,
directors are encouraged to attend annual meetings of our stockholders. Six directors attended the 2015 Annual Meeting of Stockholders. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Communications with the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Although we do not have a formal policy regarding communications with the Board of Directors, stockholders may communicate with the Board of Directors, including the non-management directors, by sending a
letter to the Sangamo Board of Directors, c/o&nbsp;Investor Relations, 501 Canal Boulevard, Richmond, California&nbsp;94804. Stockholders who would like their submission directed to a particular member of the Board of Directors may so specify.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Code of Ethics </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has adopted a Code of Business Conduct and Ethics, which is applicable to all employees and directors of the Company. A copy of our Code of Business Conduct and Ethics is available
on our website at www.sangamo.com in the Investors&nbsp;&amp; Media Section under Corporate Governance. In the event that we make any amendments to or grant any waivers of, a provision of the Code of Ethics that applies to the principal executive
officer, principal financial officer, or principal accounting officer that requires disclosure under applicable SEC rules, we intend to disclose such amendment or waiver and the reasons therefore, on our website at www.sangamo.com, in the
Investors&nbsp;&amp; Media section. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2015. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned&nbsp;or</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Paid in
Cash</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock&nbsp;
Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option&nbsp;Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (2) (3)
(4)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul B. Cleveland</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen G. Dilly, M.B.B.S., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John W. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,723</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Steven J. Mento, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Stewart Parker</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Saira Ramasastry</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William R. Ringo</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">152,723</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of the annual retainer fee for service as a member of the Board of Directors or any Board committee. For further information concerning such fees, see the
section below entitled &#147;Director Annual Retainer and Meeting Fees.&#148; </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Automatic Grant Program in effect under the Company&#146;s 2013 Stock Incentive Plan, Mr.&nbsp;Cleveland, Dr.&nbsp;Dilly, Mr.&nbsp;Larson,
Dr.&nbsp;Mento, Ms.&nbsp;Parker, Ms.&nbsp;Ramasastry and Mr.&nbsp;Ringo each received an option to purchase 10,000&nbsp;shares of common stock with an exercise price per share of $11.44 at the 2015 Annual Meeting, and each such option had an
aggregate grant date fair value of $65,223, without adjustment for estimated forfeitures. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, the following non-employee directors held options to purchase the following number of shares of the Company&#146;s common stock:
Mr.&nbsp;Cleveland, 31,667 shares; Dr.&nbsp;Dilly, 100,000 shares; Mr.&nbsp;Larson, 30,000 shares; Dr.&nbsp;Mento, 60,000 shares; Ms.&nbsp;Parker, 60,000 shares; Ms.&nbsp;Ramasastry, 44,450 shares and Mr.&nbsp;Ringo, 61,000 shares.
</FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts represent the aggregate grant date fair value of the awards in accordance with FASB Accounting Standards Codification Topic 718, or ASC 718, <I>Compensation
&#151; Stock Compensation</I>. The assumptions used in the calculation of such grant date fair values are described in Note 4 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December&nbsp;31,
2015. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Director Annual Retainer and Meeting Fees </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each non-employee Board member receives an annual cash retainer of $40,000, subject to pro-ration for directors who either join or leave the Board during the year. To the extent the Board meets more than
ten times in any year, each member of the Board will receive, for each meeting in excess of ten, a per meeting fee of $1,000 if attended in person and $500 if attended by video or telephone conference. The Chairman of the Board receives an
additional annual cash retainer of $35,000. In addition, the non-employee Board members serving as the Chairman of the Audit Committee, the Chairman of the Clinical Review Committee, the Chairman of the Compensation Committee and the Chairman of the
Nominating and Corporate Governance Committee receive an additional annual cash retainer of $20,000, $20,000, $15,000 and $10,000, respectively. Each non-employee Board member serving as a member of the Audit Committee, the Clinical Review
Committee, the Compensation Committee and the Nominating and Corporate Governance Committee, other than the Chairman, receives an additional annual cash retainer of $10,000, $10,000, $7,500 and $5,000, respectively. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Automatic Grant Program under the Company&#146;s 2013 Stock Incentive Plan (the &#147;2013 Plan&#148;) provides the Compensation
Committee with the ability to implement a program whereby directors are given the option to elect to convert their cash board retainer fees into RSU grants. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2013 Stock Incentive Plan </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under the Automatic Grant Program in effect under the 2013 Plan, on the date of each annual stockholders meeting, each continuing non-employee Board member who served as a director for the previous six
months automatically receives an option to purchase 10,000&nbsp;shares of the Company&#146;s common stock. Each option granted under the Automatic Grant Program will have an exercise price per share equal to the fair market value per share of the
Company&#146;s common stock on the option grant date and will have a maximum term of 10&nbsp;years, subject to earlier termination following the optionee&#146;s cessation of Board service. Each option is immediately exercisable for all the option
shares, but any shares purchased under the option will be subject to repurchase by the Company, at the exercise price paid per share, upon the optionee&#146;s cessation of Board service prior to vesting in those shares. The shares subject to each
automatic option grant will vest in successive equal monthly installments upon completion of each month of Board service over a one-year period. However, the shares subject to each automatic option grant will immediately vest upon (i)&nbsp;the
optionee&#146;s death or permanent disability while serving as a Board member, (ii)&nbsp;an acquisition of the Company by merger or asset sale, (iii)&nbsp;the successful completion of a tender offer for more than 50% of the Company&#146;s
outstanding voting stock or (iv)&nbsp;a change in the majority of the Board effected through one or more proxy contests for Board membership. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company anticipates that when a new non-employee director is to be elected or appointed to our Board, an equity award policy will be established that outlines the size and terms of any equity award to
be granted to such director, based on competitive market data available at such time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Automatic Grant Program provides
the Compensation Committees with discretion to grant, in lieu of the option grant that would otherwise be awarded under such program, a number of shares of restricted stock or RSUs to the non-employee directors with a fair market value substantially
equal to the grant date fair value of the option that would otherwise be awarded. In addition, the Automatic Grant Program provides the Compensation Committee with the ability to implement a program whereby directors are given the option to elect to
convert their cash board retainer fees into RSU grants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Automatic Grant Program, on the date of the 2015
Annual Meeting Mr.&nbsp;Cleveland, Dr.&nbsp;Dilly, Mr.&nbsp;Larson, Dr.&nbsp;Mento, Ms.&nbsp;Parker, Ms.&nbsp;Ramasastry and Mr.&nbsp;Ringo each received an option to purchase 10,000&nbsp;shares of common stock with an exercise price per share of
$11.44. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors recommends that the stockholders vote&nbsp;FOR the election of the nominees listed above. Unless otherwise instructed, the proxy holders named in each proxy will vote the shares
represented thereby FOR the election of the nominees named above. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;NO. 2: </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>AMENDMENT OF CERTIFICATE OF INCORPORATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Introduction and Reasons for the Amendments </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors has
unanimously determined that it is in the best interests of the Company and its stockholders to amend our Seventh Amended and Restated Certificate of Incorporation (the &#147;Certificate of Incorporation&#148;) and Second Amended and Restated Bylaws
(the &#147;Bylaws&#148;) to permit stockholders to remove our director with or without cause. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Certificate of
Incorporation and Bylaws currently provide that a director or the entire board may be removed <U>only for cause</U> by the votes of a majority of outstanding shares of the Company. Therefore, stockholders currently are not permitted to remove
directors without cause. The rights of stockholders to remove directors are governed by Section&nbsp;141(k) of Delaware General Corporation Law (DGCL). In December 2015, Delaware Chancery Court issued a decision, <I>In Re VAALCO Energy, Inc.</I>, in
which the court interpreted Section&nbsp;141(k) and held that if a company does not have (i)&nbsp;a classified board of directors or (ii)&nbsp;cumulative voting in election of directors, then such company may not provide in its certificate of
incorporation or bylaws that its directors may be removed only for cause. Prior to the <I>VAALCO</I> decision, it was not clear whether Section&nbsp;141(k) prohibits this type of provision when the company does not have classified board or
cumulative vote. The VAALCO decision made it clear that the provision is now invalid. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because the Company does not have a
classified board nor cumulative voting under its organizational documents, the <I>VAALCO</I> court decision effectively rendered our current director removal provisions in the Certificate of Incorporation and Bylaws invalid. As a result, we are now
amending these provisions to ensure that they comply with the <I>VAALCO</I> court decision, and such amendments to our Certificate of Incorporation requires stockholder approval under DCGL Furthermore, as disclosed previously in a Form 8-K filed by
the Company on March&nbsp;16, 2016, our Board has approved a resolution instructing the Company not to enforce the now invalid director removal provisions until the stockholders have approved these amendments to the Certificate of Incorporation and
Bylaws to correct them. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Description of Amendments </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We are requesting the stockholders to approve and ratify the Certificate of Amendment, as set forth in Appendix A to this proxy statement, which amends Article V, Paragraph 4 of the Certificate of
Incorporation by deleting the last sentence that prohibits removal of directors without cause, so that Article V will read as follows: </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE V. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vacancies occurring on the Board of Directors for any reason
may be filled by vote of a majority of the remaining members of the Board of Directors, even if less than a quorum, at any meeting of the Board of Directors. A person so elected by the Board of Directors to fill a vacancy shall hold office for the
remainder of the full term of the director for which the vacancy was created or occurred and until such director&#146;s successor shall have been duly elected and qualified. <STRIKE>A director or the entire Board of Directors may be removed from
office at any time only for cause by the affirmative vote of the holders of a majority of the outstanding shares of voting stock of the Corporation entitled to vote in an election of directors.</STRIKE> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The foregoing description is qualified in its entirety by the Certificate of Amendment attached as Appendix A hereto. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we are requesting the stockholders to approve and ratify Amendment No.&nbsp;1 to the Bylaws, as set forth in Appendix B to
this proxy statement, to clarify that stockholders may remove directors with or without </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
cause pursuant to the Section&nbsp;141(k) of DGCL. Specifically, Article IV, Section&nbsp;13 of the Bylaws will be amended and restated in its entirety as follows: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Any and all of the directors may be removed from office at any time, with or without cause, if such removal is approved by the
affirmative vote of the holders of at least a majority of the voting power of the issued and outstanding shares of capital stock of the Corporation then entitled to vote in the election of directors.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We note that stockholder approval of Amendment No.&nbsp;1 to the Bylaws is not required under DGCL, and that our Board of Directors has
the sole authority to amend the Bylaws without stockholder approval. However, given that Amendment No.&nbsp;1 to the Bylaws is inextricably linked to the proposed amendment to the Certificate of Incorporation, the Board believes that it is
appropriate and prudent to seek stockholder approval of Amendment No.&nbsp;1 to the Bylaws, in order to ensure that both the Certificate of Incorporation and Bylaws are consistent with the <I>VAALCO</I> court decision. The foregoing description of
the Bylaw amendment is qualified by Amendment No.&nbsp;1, which is attached as Appendix B to this proxy statement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Effects of Stockholder
Approval of Proposed Amendments </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the proposed amendment is approved and adopted, our stockholders will have the right to
remove any and all of the directors, with or without cause, by the affirmative vote of stockholders of at least a majority of our outstanding shares entitled to vote in the election of directors. As discussed above, even if the proposed amendment is
not approved by our stockholders, our Board of Directors has approved a resolution not to enforce the current director removal provisions which have been invalidated by the <I>VAALCO</I> decision. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Votes Required </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
affirmative vote of a majority of the shares of our common stock outstanding and entitled to vote at the Annual Meeting is required to approve the amendment to our Certificate of Incorporation and related Bylaw amendment. The amendment to the
Certificate of Incorporation will be effective immediately upon acceptance of filing by the Secretary of State of Delaware following stockholder approval of this proposal. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors
recommends that the stockholders vote FOR approval of the amendments to our Certificate of Incorporation and Bylaws to permit removal of directors with or without cause. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;NO. 3: </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has appointed Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm for Sangamo during 2015,
to serve in the same capacity for the year ending December&nbsp;31, 2016, and is asking the stockholders to ratify this appointment. The decision of the Board of Directors to appoint Ernst&nbsp;&amp; Young LLP was based on the recommendation of the
Audit Committee. The affirmative vote of a majority of our shares of common stock present or represented by proxy and entitled to vote is required to ratify the appointment of Ernst&nbsp;&amp; Young LLP. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event the stockholders fail to ratify the appointment, the Board of Directors will reconsider its selection. Even if the selection
is ratified, the Board of Directors in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if the Board of Directors believes that such a change would be in the best
interests of Sangamo and its stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A representative of Ernst&nbsp;&amp; Young LLP is expected to be present at the
Annual Meeting, will have the opportunity to make a statement if he or she desires to do so, and will be available to respond to appropriate questions. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Principal Accounting Fees and Services </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table presents fees
for professional audit services rendered by Ernst&nbsp;&amp; Young LLP for the audit of the Company&#146;s annual financial statements for 2015 and 2014, and fees billed for other services rendered by Ernst&nbsp;&amp; Young LLP during 2015 and 2014:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit fees and expenses (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">846,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">805,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit &#151; related fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax fees (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,775</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All other fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">894,976</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">845,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes fees and expenses for the audit of our annual financial statements included in our Forms 10-K and the related audit of internal controls over financial
reporting, review of interim financial statements included on Forms 10-Q, consultations regarding accounting and auditing matters, fees in connection with our underwritten public offering of shares of our common stock completed in March 2014, fees
in connection with the filing of the Company&#146;s registration statements on Form S-3 and Form S-8 and services normally provided in connection with statutory and regulatory filings. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes fees billed for professional services for tax compliance, tax advice and tax planning. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under its charter, the Audit Committee must pre-approve all engagements of the independent registered public accounting firm for the performance of all audit and non-audit services that are not prohibited
and the fees for such services. The Audit Committee has delegated to its Chairman the authority to evaluate and approve service engagements on behalf of the full committee in the event a need arises for specific pre-approval between committee
meetings. If the Chairman approves any such engagements, he will report such approval to the full Audit Committee not later than the next committee meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has determined that the rendering of other professional services for tax compliance and tax advice by Ernst&nbsp;&amp; Young LLP is compatible with maintaining their independence. The
Audit Committee </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
has established a policy governing our use of Ernst&nbsp;&amp; Young LLP for non-audit services. Under the policy, management may use Ernst&nbsp;&amp; Young LLP for non-audit services that are
permitted under SEC rules and regulations, provided that management obtains the Audit Committee&#146;s approval before such services are rendered. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors
recommends that the stockholders vote&nbsp;FOR the ratification of the appointment of Ernst&nbsp;&amp; Young LLP to serve as Sangamo&#146;s independent registered public accounting firm for the year ending December&nbsp;31, 2016. Unless otherwise
instructed, the proxy holders named in each proxy will vote the shares represented thereby FOR the ratification of the appointment of Ernst&nbsp;&amp; Young LLP in this proposal. </B></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OTHER MATTERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sangamo knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters properly come before the Annual Meeting, it is the intention of the persons named in
the enclosed form of Proxy to vote the shares they represent as the Board of Directors may recommend. Discretionary authority with respect to such other matters is granted by the execution of the enclosed Proxy. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANAGEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive
Officers </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information regarding our executive officers as of April&nbsp;11, 2016:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="64%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:27pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President, Chief Executive Officer and Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President, Research and Development</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Edward O. Lanphier&nbsp;II</I>, the founder of Sangamo BioSciences, Inc., has served as our President,
Chief Executive Officer and as a member of our Board of Directors since Sangamo&#146;s inception in 1995. Mr.&nbsp;Lanphier has over thirty years of experience in the pharmaceutical and biotechnology industry. From June 1992 to May 1997, he held
various positions at Somatix Therapy Corporation, a gene therapy company, including Executive Vice President, Commercial Development and Chief Financial Officer. Prior to Somatix, Mr.&nbsp;Lanphier was President and Chief Executive Officer of
BioGrowth, Inc., a biotechnology company that merged with Celtrix Laboratories to form&nbsp;Celtrix Pharmaceuticals, Inc. in 1991. From 1986 to 1987, Mr.&nbsp;Lanphier served as Vice President of Corporate Development at Biotherapeutics, Inc. From
1984 to 1986 he served as Vice President of Corporate Development at Synergen, Inc. Prior to Synergen, he was employed by Eli Lilly and Company, a pharmaceutical company, in the strategic business planning biotechnology group. He currently serves on
the board of directors of the Biotechnology Institute, the board of directors and as Chairman of the Alliance for Regenerative Medicine, the board of trustees for The Buck Institute for Research on Aging and the Dean&#146;s Advisory Board of the
University of Michigan School of Public Health. Mr.&nbsp;Lanphier received a B.A. in biochemistry from Knox College. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>H.&nbsp;Ward Wolff</I> has served as our Executive Vice President and Chief Financial Officer since December 2007. Prior to his
appointment as Executive Vice President and Chief Financial Officer, Mr.&nbsp;Wolff served as a member of the Company&#146;s Board of Directors and Chairman of the Audit Committee from June 2006 through
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
December 2007. Prior to joining the Company, Mr.&nbsp;Wolff served as Senior Vice President, Finance and Chief Financial Officer of Nuvelo, Inc. (now ARCA biopharma, Inc.) from July 2006 to
August 2007, and Chief Financial Officer and Senior Vice President, Finance, of Abgenix, Inc. from September 2004 to April 2006. From July 2002 to December 2003, Mr.&nbsp;Wolff served as Chief Financial Officer of QuantumShift. From 1998 to January
2002, he was Senior Vice President and Chief Financial Officer of DoubleTwist, Inc. From 1992 to 1998, he was Senior Vice President of Finance and Administration and Chief Financial Officer of Premenos Technology Corporation. From 1985 to 1992,
Mr.&nbsp;Wolff was an Executive Director of Russell Reynolds Associates, Inc. From 1974 to 1985, Mr.&nbsp;Wolff held numerous positions with Price Waterhouse &amp;&nbsp;Co., as a certified public accountant, including Senior Audit Manager.
Mr.&nbsp;Wolff currently serves on the board of directors of Portola Pharmaceuticals, Inc. and Calithera Biosciences, Inc. Mr.&nbsp;Wolff received a B.A. in economics from the University of California at Berkeley and an M.B.A. from Harvard Business
School. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Geoffrey M. Nichol, M.B., Ch.B.,</I> has served as our Executive Vice President, Research and
Development since July 2011. Dr.&nbsp;Nichol has over twenty years of experience in the pharmaceutical and biotechnology industries and has made contributions in all stages of the drug development process from program initiation, through all phases
of clinical evaluation to product approval. He has been closely associated with the development of over 15 new drug candidates and the approval and/or launch of several marketed drugs, including Augmentin BID, Foradil<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and Yervoy&#153;. Dr.&nbsp;Nichol has particular expertise in development of platform technologies. From 2002 to
2010, he served as Senior Vice President of Product Development at Medarex, Inc., where he was responsible for all aspects of the clinical development of therapeutic products based on a fully-human monoclonal antibody platform. From 1996 to 2002, he
held various senior management positions at Novartis Pharmaceuticals, including Vice President, U.S. Medical Affairs and Vice President and Global Head, Project Management, and in the seven years prior held management positions in drug development
with SmithKline Beecham Pharmaceuticals. Most recently, Dr.&nbsp;Nichol served as Chief Medical Officer of Ikaria, Inc., a biotherapeutics company. Dr.&nbsp;Nichol earned his B.Med.Sc., M.B., Ch.B., or the equivalent of an M.D. in the U.S., from
Otago University Medical School in New Zealand and received an M.B.A. from Warwick University in the United Kingdom. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information known to Sangamo with respect to the beneficial ownership of our common stock as of
April&nbsp;8, 2016, by (i)&nbsp;all persons who were beneficial owners of five percent (5%)&nbsp;or more of our common stock based on 70,400,119&nbsp;shares outstanding as of April&nbsp;8, 2016, (ii)&nbsp;each director and each nominee for director,
(iii)&nbsp;the executive officers named in the Summary Compensation Table of the Executive Compensation of this Proxy Statement, and (iv)&nbsp;all current directors and named executive officers as a group. Unless otherwise indicated, the principal
address of each of the stockholders below is c/o&nbsp;Sangamo BioSciences, Inc., 501&nbsp;Canal Boulevard, Richmond, CA 94804. Except as otherwise indicated or to the extent authority may be shared by both spouses under applicable law, and subject
to applicable community property laws, we believe the persons named in the table have sole voting and investment power with respect to all shares of common stock held by them. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:134pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Address of Beneficial Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficially</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Owned</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of
Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficially</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Owned (17)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Wasatch Advisors, Inc. (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,099,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">505 Wakara Way</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salt Lake City, UT 84108</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc. (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,790,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 East 52</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">nd</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Street</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">New York, NY 10055</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">FMR LLC (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,239,783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">245 Summer Street</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02210</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Baker Bros. Advisors (GP) LLC (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,055,876</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">667 Madison Avenue, 21</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">st</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Floor</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">New York, NY 10065</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,856,010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Paul B. Cleveland (6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen G. Dilly, M.B.B.S., Ph.D. (7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John W. Larson (8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">244,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Steven J. Mento, Ph.D. (9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,214</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Stewart Parker (10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Saira Ramasastry (11)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William R. Ringo (12)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff (13)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,032,525</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B. (14)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">550,613</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert F. Carey</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">112,744</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D. (15)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">516,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All current directors and named executive officers as a group (13 persons) (16)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,704,477</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than one percent. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule&nbsp;13G/A filed on February&nbsp;10, 2016, Wasatch Advisor, Inc. is the beneficial owner of 7,099,209 shares of common stock and has sole power
to vote or to direct to vote such shares, and the sole power to dispose or direct the disposition of such shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule 13G/A filed on January&nbsp;22, 2016, BlackRock, Inc., as the parent holding company of various subsidiaries that acquired shares of our common
stock, is the beneficial owner of 4,790,474 shares of common stock. BlackRock, Inc. has sole power to dispose or to direct the disposition of 4,790,474 shares of common stock and sole power to vote or to direct to vote of 4,613,119 shares of common
stock. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule 13G filed on February&nbsp;12, 2016, FMR LLC is the beneficial owner of 4,239,783 shares of common stock and has sole power to dispose and
direct the disposition of 4,239,783 shares of common stock. Edward C. Johnson is a Director and Chairman of FMR LLC and Abigail P. Johnson is a Director, the Vice Chairman, the Chief Executive Officer and the President of FMR. As such, and through
their ownership interests of FMR LLC, each of Mr.&nbsp;Johnson and Ms.&nbsp;Johnson has sole power to dispose and direct the disposition of 4,239,783 shares of common stock. Neither FMR LLC nor Mr.&nbsp;Johnson nor Ms.&nbsp;Johnson has sole power to
vote or direct the voting of shares beneficially owned by them. Select Biotechnology Portfolio is reported to have sole power to vote and direct the voting of 4,239,783 shares of common stock beneficially owned by FMR LLC, </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule 13G filed on February&nbsp;16, 2016, Baker Bros. Advisors (GP) LLC is the beneficial owner of an aggregate of 4,055,876 shares of common stock,
consisted of 298,646 shares directly held by 667, L.P. and 3,757,230 shares directly held by Baker Brothers Life Science, L.P. Baker Bros. Advisors (GP) LLC is the general partner of Baker Bros. Advisors LP, which is the general partner of each of
667, L.P. and Baker Bros. Advisors LP and Baker Brothers Life Science, L.P. Baker Bros. Advisors (GP) LLC has sole power to vote or to direct to vote 4,055,876 shares, and the sole power to dispose or direct the disposition of such shares. The
principals of Baker Bros. Advisors (GP) LLC are Felix J. Baker and Julian C. Baker, who may be deemed to have beneficial ownership of the shares held by Baker Bros. Advisors (GP) LLC but disclaim such beneficial ownership. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 1,622,916 shares of common stock subject to options exercisable within 60&nbsp;days after April&nbsp;8, 2016. Also includes 1,233,094&nbsp;shares held in
family trust. Excludes Restricted Stock Units (&#147;RSUs&#148;) covering an additional 233,333 shares of common stock that may vest and become issuable more than 60 days after April&nbsp;8, 2016. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 31,667 shares issuable upon the exercise of stock options within 60 days of April&nbsp;8, 2016, of which 30,833 shares fully vest within 60 days of
April&nbsp;8, 2016. The remaining 834 shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 100,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;8, 2016, of which 99,166 shares fully vest within 60 days of
April&nbsp;8, 2016. The remaining 834 shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 30,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;8, 2016, of which 29,166 shares fully vest within 60 days of
April&nbsp;8, 2016. The remaining 834 shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. Also includes 11,260&nbsp;shares of common stock held
in Mr.&nbsp;Larson&#146;s individual retirement account (IRA). </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 60,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;8, 2016, of which 59,166 shares fully vest within 60 days of
April&nbsp;8, 2016. The remaining 834 shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. Also includes 32,214&nbsp;shares held in a family
trust. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes of 60,000 shares issuable upon the exercise of stock options, of which 41,111&nbsp;shares fully vest within 60 days of April&nbsp;8, 2016. The remaining 18,889
shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 44,450 shares issuable upon the exercise of stock options, of which 43,616&nbsp;shares fully vest within 60 days of April&nbsp;8, 2016. The remaining 834
shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 61,000 shares issuable upon the exercise of stock options within 60 days of April&nbsp;8, 2016, of which 60,166 shares fully vest within 60 days of
April&nbsp;8, 2016. The remaining 834 shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to Board if exercised prior to vesting. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 889,603 shares of common stock subject to options exercisable within 60&nbsp;days after April&nbsp;8, 2016. In addition to the shares reported as beneficially
owned by Mr.&nbsp;Wolff in the table above, he also holds RSUs covering an additional 74,166 shares of common stock that may vest and become issuable more than 60 days after April&nbsp;8, 2016. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 465,103 shares of common stock subject to options exercisable within 60&nbsp;days after April&nbsp;8, 2016. Excludes RSUs covering an additional 85,510 shares
of common stock that may vest and become issuable more than 60 days after April&nbsp;8, 2016. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 457,546&nbsp;shares of common stock subject to options exercisable within 60&nbsp;days after April&nbsp;8, 2016. Excludes RSUs covering an additional 49,332
shares of common stock that may vest and become issuable more than 60 days after April&nbsp;8, 2016. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 3,822,285 shares issuable upon the exercise of stock option, of which 3,798,392 shares are fully vested within 60 days of April&nbsp;8, 2016. The remaining
23,893 shares do not vest within 60 days of April&nbsp;8, 2016 and would be subject to repurchase upon cessation of service to the Board if exercised prior to vesting. Excludes RSUs covering an additional 442,341 shares of common stock that may vest
and become issuable more than 60 days after April&nbsp;8, 2016. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The percentages are calculated based on 70,400,119&nbsp;shares outstanding as of April&nbsp;8, 2016.&nbsp;Shares of common stock issuable upon the exercise of options
currently exercisable or exercisable within 60&nbsp;days after April&nbsp;8, 2016, are deemed outstanding for purposes of computing the percentage ownership of the person holding such options, but are not deemed outstanding for computing the
percentage ownership of any other person. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>COMPENSATION DISCUSSION AND ANALYSIS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">It is our intent in this Compensation Discussion and Analysis (&#147;CD&amp;A&#148;) to inform our stockholders of the policies and
objectives underlying the compensation programs for our executive officers. Accordingly, we will address and analyze the key elements of the compensation provided to our chief executive officer, our principal financial officer and the senior
research and clinical development executive officers named in the Summary Compensation Table which follows this discussion. We refer to these officers as our named executive officers. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Summary of Compensation Principles and Decisions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Company&#146;s overarching compensation goal is to reward our executive officers in a manner that supports a strong pay-for-performance philosophy in order to create a positive relationship between its compensation program and the Company&#146;s
operational performance and stockholder return, while maintaining an overall level of compensation that the Company believes is fair, reasonable and responsible. The Company believes its compensation objective is accomplished through the following
principles and processes that are followed in establishing executive compensation and by the following decisions made with respect to the 2015 compensation package for our named executive officers: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to assure that the compensation programs for the executive officers remain competitive with peer companies, accomplish the Company&#146;s
pay-for-performance objectives, and create rewards for the realization of our long-term strategic objectives, the Compensation Committee works with an independent consultant, Radford, an Aon Hewitt Company (&#147;Radford&#148;), to obtain the advice
and market data needed to ensure that the compensation programs achieve these goals. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s 2015 cash incentive program provided our executive officers with a direct financial incentive in the form of a cash bonus award tied
to the Company&#146;s achievement of aggressive pre-established clinical, research and development, business and corporate development, and financial objectives for the 2015 year, as well as individual performance objectives for Dale Ando, our Vice
President, Therapeutic Development and Chief Medical Officer and Philip Gregory, who served as Senior Vice President, Research and Chief Scientific Officer until his employment terminated in June 2015. For 2015, the Compensation Committee
established a maximum payout of 200% of target bonuses based on attainment of the corporate performance goals. The Compensation Committee determined that 85% of the corporate objectives for the 2015 year were achieved, and that the individual
performance objectives for Dr.&nbsp;Ando were achieved at 90%. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not offer a defined benefit pension plan, deferred compensation plan or supplemental executive retirement plan. Instead, the Company
relies on equity compensation (in the form of stock options and restricted stock units) in order to attract and retain key employees, align the interests of our executive officers with those of our stockholders and to provide our executive officers
and other employees with the opportunity to accumulate retirement income. However, the Compensation Committee is committed to using equity incentive awards prudently and within reasonable limits. Our historic three-year average gross burn rate,
representing annual equity award grants as a percentage of total shares outstanding is 3.32%, calculated in accordance with the methodology used by Institutional Shareholder Services (ISS). This is below the 6.77% gross burn rate limit for 2015 that
ISS applies to the Pharmaceutical and Biotechnology GICS industry group of the Russell 3000 to which the Company belongs. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The base salary increases for our executive officers were modest, and generally consistent with salary increases for our other employees.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has entered into employment agreements with its President and Chief Executive Officer, Edward O. Lanphier II, its Executive Vice President,
Research and Development, Dr.&nbsp;Geoffrey Nichol and its Executive Vice President and Chief Financial Officer, H. Ward Wolff. These agreements provide financial protection against the potential loss of employment in designated circumstances,
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
which the Compensation Committee believes will allow the executives to focus attention on the best interests of the stockholders, without undue concern as to the executive&#146;s own financial
situation. None of our employment agreements contain a tax gross-up. The Compensation Committee has been advised by its independent compensation consultant that the benefits provided under these agreements are consistent with both peer company and
broader market practices, and are fair and reasonable. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee annually assesses whether our compensation programs have potential risks that are reasonably likely to have a material
adverse effect on the Company. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not offer any significant perquisites to the executive officers. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2015 Business Highlights </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As discussed in this CD&amp;A, the Compensation Committee strives to create a positive relationship between its compensation program and
the Company&#146;s operational performance and stockholder return. The Compensation Committee established the 2015 compensation program and the associated Company goals in accordance with this philosophy and recognized the following key financial
and operational achievements during the 2015 year: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2015 the Company announced that it had in-licensed nanoparticle technology to enable systemic messenger RNA (mRNA) delivery of
Sangamo&#146;s proprietary zinc finger nucleases (ZFNs). mRNA delivery of ZFNs is being used in the development of the next generation of Sangamo&#146;s ZFP Therapeutics<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2015 the company announced a strategic decision by Sangamo and its partner Shire to revise their January 2012 collaboration and license
agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington&#146;s disease. Under the revised terms of the agreement, Shire returned to Sangamo the exclusive world-wide rights to gene targets for the development,
clinical testing and commercialization of ZFP Therapeutics for hemophilia A and B and Shire retained rights to the Huntington&#146;s disease program and a ZFP Therapeutic for one additional gene target yet to be named. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 2015 Sangamo announced the clearance by the U.S. Food and Drug Administration (FDA) of an Investigational New Drug (IND) application for
the company&#146;s SB-BCLmR-HSPC genome editing approach for beta-thalassemia which developed in collaboration with Biogen. Subsequently, in May 2015, the Company announced the decision of the collaboration&#146;s joint steering committee (JSC)
governing the programs to consolidate the strategy for the beta-thalassemia and sickle cell disease (SCD) programs. This involved a modification of the therapeutic approach for the beta-thalassemia program from knockout of the BCL11A gene to
knockout of the BCL11A Enhancer, an approach that was already under development for the SCD program. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the fourth quarter of 2015 IND applications were filed with the FDA for two clinical programs, to address hemophilia B and Mucopolysaccharidosis I
(MPS I or Hurler syndrome). The FDA reviewed and accepted both applications and the INDs are active, enabling the Company to begin Phase 1/2 clinical trials for these indications in 2016. Phase 1 study protocols for both programs were also reviewed
by the National Institutes of Health&#146;s Recombinant DNA Advisory Committee (RAC) and received unanimous approval. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2015 the Company presented clinical data from its SB-728-T program at several scientific and medical conferences including data demonstrating the
superiority of SB-728-T produced using adenoviral delivery to both CD4 and CD8 cells (SB-728-1101) over that produced with mRNA delivery (SB-728-1401). The company reported that two of three subjects treated in the SB-728-1101 clinical study were
able to maintain viral load control in the absence of antiretroviral therapy (ART) and remained off ART for over one year. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company presented positive preclinical data from its In Vivo Protein Replacement Platform (IVPRP) programs for proprietary ZFP Therapeutics<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> designed to provide long lasting treatments for
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
lysosomal storage disorders (LSDs) and hemophilia. Data were presented at several meetings including the WORLDSymposium&#153; 2015 Meeting, the Annual Meeting of the American Society for Gene and
Cell Therapy (ASGCT) and the American Society for Hematology Annual Meeting (ASH). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company concluded 2015 with $209.3 million in cash, cash equivalents, investments and interest receivable. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Overview of the Company&#146;s Executive Compensation Program </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Corporate Governance and the Role of the Compensation Committee </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee assists the Board of Directors in fulfilling its fiduciary responsibilities with respect to the oversight of the Company&#146;s affairs in the areas of compensation plans, policies and programs of the Company, especially those
regarding executive compensation and employee benefits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee&#146;s responsibilities include
(i)&nbsp;establishing, administering and reviewing compensation plans and programs for the Company&#146;s executive officers and other employees, including incentive and equity-based plans and programs; (ii)&nbsp;establishing compensation
arrangements for the executive officers and setting the performance goals for their incentive compensation programs; (iii)&nbsp;evaluating the performance of executive officers and awarding incentive compensation; (iv)&nbsp;adjusting compensation
arrangements as appropriate based upon performance; and (v)&nbsp;reviewing and monitoring management development and succession plans and activities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During 2015 Dr.&nbsp;Mento served as Chairman of the Compensation Committee, and Messrs. Larson and Ringo served as members of the Compensation Committee. The Company&#146;s Board of Directors has
determined that all of the Compensation Committee members who served during the 2015 year are &#147;independent&#148; directors under the NASDAQ definition of independence. Dr.&nbsp;Mento and Messrs. Larson and Ringo have extensive experience in
executive management and the biotechnology industry, including experience with compensation practices and policies. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Objectives of the
Company&#146;s Compensation Program </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company is developing a new class of human therapeutics and is committed to
building a sustainable business focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs. To achieve this strategic objective, the
Company has emphasized the recruitment of executives with significant industry or scientific experience. This is a very competitive industry and our success depends upon our ability to attract and retain qualified executives through competitive
compensation packages. The Compensation Committee administers the compensation programs for our executive officers with this competitive environment in mind. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pharmaceutical research, development and commercialization require sustained and focused effort over many years, and involves a high degree of risk, particularly in the early stages of clinical
development. As a consequence, the Compensation Committee believes the Company&#146;s compensation program must balance long-term incentives that create rewards for the realization of our long-term strategic objectives with near term compensation
that rewards employees for the achievement of annual goals that further the attainment of the Company&#146;s long-term objectives and align the interests of our employees with those of our stockholders. The Company believes that compensation should
not be based primarily on the near-term performance of our stock, which has been and continues to be highly volatile. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To this
end, the objectives of the Company&#146;s compensation program are to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enable the Company to attract and retain highly qualified executives with extensive industry or scientific experience by providing a competitive
compensation package that includes long-term incentives that provide significant retentive value; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reward executives for the Company&#146;s success in meeting its annual clinical development and other research and operational goals;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reward executives for their individual performance and achievement of their personal goals and those of the functional organizations that they manage;
and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Align the interests of our executives with those of our stockholders. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Executive Compensation Determination Procedures and Policies </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee reviews executive compensation annually. As part of this process, the Chief Executive Officer makes recommendations to the Compensation Committee with respect to the compensation levels for individual executives other than
himself based on the performance evaluation conducted by the executive&#146;s manager. The Compensation Committee reviews this information and adjusts or approves the recommendations as appropriate. In making its determination for each named
executive officer, the Compensation Committee considers the Company&#146;s performance against annual and longer term objectives, market data regarding executive compensation at comparable companies and realized and realizable values under previous
equity awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of the Chief Executive Officer, the Compensation Committee evaluates his performance against the
Company&#146;s annual goals and longer term objectives pre-established by the Board of Directors, together with market data regarding executive compensation at comparable companies and realized and realizable values under previous equity awards.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee retained the services of Radford in order to (i)&nbsp;assess compensation levels and mix of
elements for the Company&#146;s executive officers and vice presidents for 2015, (ii)&nbsp;review of the peer group companies selected in 2014 and recommend any changes to that list and (iii)&nbsp;advise the committee on executive compensation and
governance trends based on peer group trends and market practices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee determined that Radford was
independent using certain defined criteria including (i)&nbsp;fees paid by Sangamo to Radford as a percentage of Radford&#146;s total revenue; (ii)&nbsp;other services provided to Sangamo by Radford or Radford&#146;s parent company Aon plc;
(iii)&nbsp;Radford&#146;s business or personal relationships with Compensation Committee members and executive officers; (iv)&nbsp;shares of Sangamo common stock owned by Radford; and (v)&nbsp;other potential conflicts of interest. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Comparative Analysis </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of measuring the competitive positioning of our compensation packages, peer companies are generally selected by the
Compensation Committee primarily using the following criteria, with a general preference for companies located in northern California: (i)&nbsp;publicly-held pre-commercial U.S. biotechnology companies, (ii)&nbsp;companies with 50 &#150; 500
employees, and (iii)&nbsp;companies that fall within a specific market capitalization range of approximately one half to two times Sangamo&#146;s market capitalization at the time of the peer evaluation. Because the biotechnology industry is a
dynamic industry, the comparator group used by the Compensation Committee to measure the competitive positioning of our compensation packages is periodically updated to ensure that companies continue to meet the established criteria. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The selected comparable companies for purposes of measuring the competitive positioning of
the base salary and cash incentive bonus elements of the compensation packages in 2015 were as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">ACADIA Pharmaceuticals</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Infinity&nbsp;Pharmaceuticals,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alnylam Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Isis Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Anacor Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">MannKind Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">bluebird bio, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neurocrine Biosciences, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Celldex Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Osiris Therapeutics, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dyax Corp.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sarepta Therapeutics, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dynavax Technologies Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Synta Pharmaceuticals Corp.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ultragenyx&nbsp;Pharmaceutical,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">XenoPort, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">ImmunoGen, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">XOMA Corporation</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In October 2015 the Compensation Committee, based on the recommendation of Radford, revised the market
capitalization criteria used to identify peer companies to those companies that fall within a market capitalization range of approximately 0.3 to 3 times Sangamo&#146;s market capitalization and updated the comparator group to ensure that companies
continue to meet the revised established criteria. The selected comparable companies for purposes of measuring the competitive positioning of the equity compensation awards issued in December 2015 were as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">ACADIA Pharmaceuticals</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">MannKind&nbsp;Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">bluebird bio, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neurocrine&nbsp;Biosciences,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Celldex Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Osiris Therapeutics, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">ChemoCentryx, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peregrine&nbsp;Pharmaceuticals,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cytokinetics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rigel Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dyax Corp.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sarepta Therapeutics, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dynavax Technologies Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Synta Pharmaceuticals Corp.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Threshold Pharmaceutical, Inc</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ultragenyx&nbsp;Pharmaceutical,&nbsp;Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">ImmunoGen, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">XenoPort, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Infinity Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Key Elements of the Company&#146;s Executive Compensation Program </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following are the key elements of the Company&#146;s executive compensation program: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Base Salary </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Incentive Bonus </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity Compensation </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">Base salary is intended to enable the Company to attract and retain skilled and experienced executives and to provide a level of economic security for executives from year to year. For each of the
Company&#146;s officers, the Compensation Committee generally begins by targeting base compensation in the range of the
50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> to 75</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the market data derived by Radford from the comparator
group. The Committee considers this positioning appropriate given the high cost of living in the San Francisco Bay Area. However, the base salary for a specific executive officer may then be targeted below or above the range based on individual
performance, experience, skills and the importance of the executive&#146;s position to the Company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">In accordance with our practice, in December 2014 the Company conducted
annual performance reviews for the 2014 year for all of its employees, including named executive officers. Based on these reviews, Company performance for the 2014 year, advice from Radford and competitive data from the peer group, the Compensation
Committee approved increases in annual base salaries for each of the Company&#146;s named executive officers, effective January&nbsp;1, 2015. The base salary increases for the other executive officers were modest. In general, the base salaries of
those executive officers for 2015 were at or above the
75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the market data derived from the peer
group. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The base salaries established for 2015 and 2014 were as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Base&nbsp;
Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Base&nbsp;
Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Increase</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">675,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">650,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">405,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">470,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">460,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil. (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">450,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">425,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">450,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">440,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Gregory&#146;s employment terminated in June 2015. $225,863 represents the actual salary paid through the end of his employment. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cash Incentive Bonus for 2015 </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Incentive Compensation Plan Terms and Conditions </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation
Committee has adopted the Sangamo BioSciences, Inc. Incentive Compensation Plan (the &#147;Incentive Plan&#148;) as a performance-based cash bonus program for the Company&#146;s executive officers. The Compensation Committee has discretion under the
Incentive Plan to implement one or more performance periods under the plan, each of a duration determined by the Compensation Committee. The Incentive Plan includes a list of criteria, one or more of which may be used to establish performance
objectives under the Incentive Plan, including both individual and Company performance objectives. For each Company and individual objective, the Compensation Committee may set differing levels of attainment. The Compensation Committee will then
establish dollar levels for the bonus to which each participant may become entitled for that performance period based on the level at which the performance objectives are actually attained. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A participant will not become entitled to a bonus under the Incentive Plan for a particular performance period unless the participant
remains employed by the Company through the date bonuses are paid to each participant following completion of that performance period. However, should a change in control transaction be consummated prior to the completion of a performance period,
then the performance period will terminate upon the consummation of that change in control and each participant in the Incentive Plan will receive a bonus in the dollar amount previously set by the Compensation Committee at target level attainment
of each performance objective; however, such bonus will be pro-rated to reflect each participant&#146;s actual period of service from the start date of the performance period through the effective date of the change in control. The pro-rated bonus
paid pursuant to the terms of the Incentive Plan will reduce the amount of any severance payable to the participant based on the participant&#146;s target bonus pursuant to the terms of any employment agreement. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2015 Objectives and Achievement </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The cash incentive program for the 2015 year under the Incentive Plan was designed to advance our pay-for-performance policy by focusing the attention of our executive officers on the attainment of key
Company short-term objectives that further the attainment of the Company&#146;s long-term objectives. The program provided each of our executive officers with a direct financial incentive in the form of a cash bonus award tied to our achievement of
aggressive pre-established clinical, research and development, business and corporate development, and financial goals for the 2015 year based on our annual operating plan for such year. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Given the uncertainties involved in pharmaceutical development, the Compensation
Committee&#146;s milestones for certain clinical and research objectives have typically focused on the achievement of a specific milestone, rather than a successful outcome. The Compensation Committee believes that this focus is appropriate for the
cash incentive program because the executive officers are already incentivized to produce successful outcomes pursuant to outstanding equity awards, as described under the heading &#147;Equity Compensation&#148; below. The Compensation Committee
also believes that this strategy protects against the potential of short-term incentives to encourage excessive risk taking. However, in order to advance our pay-for-performance strategy, and align our cash incentive program with the interests of
our stockholders, the Compensation Committee has increasingly focused our corporate objectives under the Incentive Plan on the successful achievement of milestones related to the attainment of the Company&#146;s long-term objectives, and the
creation of stockholder value. The Compensation Committee determined the relative weight of each goal under the cash incentive program based on its importance to the Company&#146;s success. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has historically determined the size of potential cash bonuses by reference to target bonus amounts, based on
market data from the peer group for each executive position. The specified percentages are intended to help ensure that the Company&#146;s total cash compensation is competitive when compared to the peer companies. It is also designed to ensure that
a portion of each executive&#146;s cash compensation is contingent on goal achievement, thereby increasing the performance-based component of each executive&#146;s total compensation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the performance period under the Incentive Plan coincident with the 2015 calendar year, the target cash bonus for our executive
officers was as follows: Mr.&nbsp;Lanphier, 60% of base salary; Dr.&nbsp;Nichol, 45% of base salary; Mr.&nbsp;Wolff, 40% of base salary, and Drs. Ando and Gregory, 35% of base salary. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Messrs. Lanphier and Wolff and Dr.&nbsp;Nichol, 100% of the target bonus was based on pre-established corporate performance
objectives; for Drs. Ando and Gregory, 80% of the target bonus was based on corporate performance objectives and 20% of the target bonus was based on individual performance objectives. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the actual level of achievement for any category of objectives was deemed to be below the target level for that category of
objectives, the dollar amount of the portion of the executive officer&#146;s bonus allocated to that category of objectives was calculated on a proportional basis between $0 and his target bonus amount. If performance exceeded the target level for
that category of objectives, the dollar amount of the portion of the bonus allocated to that category of objectives was increased at the discretion of the Compensation Committee above the target bonus amount for that category of objectives to
reflect the extent to which the results exceeded the target. The aggregate percentage attainment of the corporate performance objectives had to be at a minimum of 70% for any bonuses to become payable. The maximum bonus attributable to achievement
of the corporate performance objectives at a level above 100% in the event of exceptional performance was limited to 200% of target bonus. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The principal individual performance objective for Dr.&nbsp;Ando was to achieve the development component of the Company&#146;s performance objectives. In addition, Dr.&nbsp;Ando&#146;s individual
performance objectives related to implementation of organizational enhancements and expanding technical expertise in the Company&#146;s development group and continuing to build key relationships with clinical opinion leaders. The principal
individual performance objective for Dr.&nbsp;Gregory was to achieve the research component of the Company&#146;s performance objectives. In addition, Dr.&nbsp;Gregory&#146;s individual performance objectives related to implementation of
organizational enhancements in the research group, strategic contributions to the scientific direction of the Company and support of the business development group. The maximum achievement for Drs. Ando and Gregory&#146;s individual performance
objectives was 125% of target. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the time the objectives were set, we believed that the objectives, though aggressive, were
achievable at the established target levels, but substantial uncertainty nevertheless existed as to the actual achievement of the objectives at the established level. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The performance objectives, weighting and achievement under the program for 2015 may be
summarized as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:152pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate Performance Objectives For 2015</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:44pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Achievement</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Clinical Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10%</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(50%&nbsp;of&nbsp;category)</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advance clinical trials of SB-728-T
program</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advance clinical trials of beta thalassemia
program</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and Clinical Development Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42.5%</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(85% of
category)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Milestones related to the submission of
INDs</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advance preclinical pipeline of ZFP
Therapeutics</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other research and clinical development
objectives related to manufacturing and regulatory activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Business/Corporate Development Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15%</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(100%&nbsp;of&nbsp;category)</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluate and complete at least one ZFP Therapeutic
corporate partnership</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evaluate, license or acquire
additional technologies or synergistic products</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10% + 2.5% bonus</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(125% of
category)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advance prioritized ZFP Therapeutic research
programs</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secure new grant funding to support preclinical
programs</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Achieve all development deliverables under the
agreements with Shire and Biogen</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other research
objectives</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Finance and Organizational Objectives:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5%</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(100% of
category)</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Conclude 2015 with more than $180.0 million in cash and cash equivalents, excluding
cash from new corporate partnerships or financing activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">100%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">85%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee determined that the Company&#146;s performance for the 2015 year resulted in
total achievement of 85% of the weighted objectives (see table above for specific objective achievement). The Compensation Committee determined the level of achievement of the Business/Corporate Development Objectives, the Research Objectives and
the Finance and Organizational Objectives, based on the results achieved by the Company in executing those objectives, as described above under the heading &#147;2015 Business Highlights.&#148; In addition, the Compensation Committee determined that
Dr.&nbsp;Ando met his individual performance goals at 90% (or 18% of the 20% for that category). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee
retains the discretion each year to grant supplemental bonuses under the Incentive Plan to named executive officers that are above or below the established target based on the above criteria and its subjective assessment of each named executive
officer&#146;s performance. No such discretionary bonuses were awarded for 2015. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The table below sets forth the target and
actual cash incentive program awards for our named executive officers based on the Company&#146;s performance in the 2015 year, and for Drs. Ando, achievement of individual performance objectives: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">405,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">344,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">166,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">141,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">211,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">179,775</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">157,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">135,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Equity Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company has historically granted stock options to its executives, and to all of its employees, to provide long-term incentives that align the interests of its work force with the achievement of the
Company&#146;s long-term vision to develop and commercialize pharmaceutical products and with the interests of the Company&#146;s stockholders. Given the time periods involved in pharmaceutical development, the Company believes that these long-term
incentives are critical to the Company&#146;s success. The exercise price for options granted by the Company is equal to the closing price of the Company&#146;s stock on the option grant date. Accordingly, stock options produce realizable value to
the holder only if the Company&#146;s stock price increases over the period of time that the award remains outstanding. Option grants are typically subject to a four year vesting schedule with 25% of the grant vesting on the first anniversary of the
grant and then monthly thereafter for the next three years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee began awarding RSUs to its executive
officers and certain employees beginning in December 2011. The committee made that change for a number of reasons, including reducing the dilutive effect of the incentive equity awards made to management, making the Company&#146;s equity
compensation practices competitive with the Company&#146;s peer group and providing additional retention incentive. Each RSU entitles the recipient to one share of our common stock at a designated issue date following the vesting of that unit,
without the payment of an exercise price or other cash consideration for the issued share. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the advice of Radford and
its review of peer group data, for several years the Compensation Committee has generally awarded equity packages consisting of both RSU awards and stock options. The Compensation Committee believes that an equity package utilizing both RSU awards
and stock options enables the committee to balance the positive and negative attributes of each type of equity award. For example, stock options are generally considered to have a stronger pay-for-performance component since the awards result in
realizable value to the executive only if the company&#146;s stock price increases over time. For this reason, higher numbers of option shares are generally awarded by companies, increasing stockholder dilution, but also providing a greater return
to the executive when the company&#146;s stock price increases. RSUs retain value when the company&#146;s stock price decreases, and accordingly are considered to have a stronger retention value, particularly in volatile markets. Because RSUs retain
value when the stock price decreases, companies generally award smaller numbers of RSUs than they would stock options, thereby resulting in less stockholder dilution. Consistent with the awards made in past years, the equity awards in 2015 were
granted with a 2:1 award ratio of stock options to RSUs. The approximate mix awarded to the executive officers in 2015 was 50% stock options and 50% RSUs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following equity awards were granted to our named executive officers by the Compensation Committee effective December&nbsp;8, 2015: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares
at an</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise Price Per</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Share of $9.41</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Restricted&nbsp;
Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Units</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">The committee generally targets equity compensation values for the Company&#146;s
officers in the range of the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> to 75</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile of the market data derived by Radford from the comparator
group. However, the equity award value for a specific executive officer may be targeted below or above the range based on individual performance, experience, skills and the importance of the executive&#146;s position to the Company. As a result of
the strength of our current executive team as measured against those factors, the equity award values of our executive officers were at in the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile range, except for the equity award value of our Chief Executive Officer, which was in the range of the
75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The stock options awarded in December 2015 are subject to a four year vesting schedule with
25% of the grant vesting on the first anniversary of the grant and then monthly thereafter for the next three years. The RSUs awarded in December 2015 vest and the underlying shares of common stock will become issuable in three successive equal
annual installments measured from the grant date. The equity awards granted to Messrs. Lanphier and Wolff and Dr.&nbsp;Nichol are subject to accelerated vesting in whole or in part in the event the officer&#146;s employment terminates under certain
circumstances or upon certain changes in control or ownership of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because our executive officers have generally
retained their equity awards for significant time periods, thereby aligning the interests of our executive officers with the interests of our stockholders, we have not adopted a policy requiring our executive officers to hold their equity awards for
any designated period of time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity awards are granted to all employees, including executives, when they are hired, and
employees are eligible for additional equity awards in connection with annual performance reviews in December of each year. New hire equity awards are generally pre-authorized and become effective on the employee&#146;s start date, with the exercise
price of any stock option grants set at the closing price of the Company&#146;s stock on that date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Employment Agreements </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has entered into an employment agreement with Messrs. Lanphier and Wolff and with Dr.&nbsp;Nichol. These agreements provide
financial protection against the potential loss of employment in designated circumstances, which the Compensation Committee believes will allow the executives to focus attention on the best interests of the stockholders, without undue concern as to
the executive&#146;s own financial situation. None of our employment agreements contain a tax gross-up. The Compensation Committee has been advised that the benefits provided under these agreements are consistent with both peer company and broader
market practices, and are fair and reasonable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A summary of the material terms of the employment agreements with Messrs.
Lanphier and Wolff and with Dr.&nbsp;Nichol, together with a quantification of the benefits available under those agreements, may be found in the section of the Proxy Statement entitled &#147;Employment Contracts and Change in Control
Arrangements.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Other Elements of Executive Compensation Program </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The remaining elements of the Company&#146;s executive compensation program, like its broader employee compensation programs, are intended
to make the Company&#146;s overall compensation program competitive with those of its peer companies, keeping in mind the constraints imposed by the Company&#146;s reliance on the capital markets as the primary source of its cash needs. With the
exception of the employment agreements between the Company and the Company&#146;s President and Chief Executive Officer, Executive Vice President and Chief Financial Officer and Executive Vice President, Research and Development, all of the
remaining elements of the Company&#146;s executive compensation program (401(k)&nbsp;Plan, Medical, Dental, and Vision Plans, Life and Disability Insurance, and Employee Stock Purchase Plan) are available to all Company employees. Under the terms of
the Company&#146;s Employee Stock Purchase Plan and the Internal Revenue Code, as a beneficial owner of more than 5% of the Company&#146;s outstanding common stock, Mr.&nbsp;Lanphier is not eligible to participate in that plan. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Allocations between Base Salary, Cash Incentive Bonus and Equity Compensation for Executives and Risk-Taking </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As discussed above, the development and commercialization of pharmaceutical products involves a high degree of risk, particularly in the
early stages of clinical development. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has sought to align equity and cash components with industry peers in order
to offer compensation packages that enable us to attract and retain talented employees, including those in the Company&#146;s executive ranks. The Compensation Committee continues to evaluate the relative importance of equity and cash components of
total compensation. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not believe that the performance-based nature of the executive compensation
program encourages excessive risk-taking by its executive officers that would threaten the economic viability of the Company. Some clinical milestones under the cash incentive program each year are generally focused on the achievement of a specific
milestone, rather than a successful outcome. The Compensation Committee believes that this strategy protects against the potential of near-term incentives to encourage excessive risk taking. In addition, long-term equity awards tied to the value of
the Company&#146;s common stock represent a significant component of an executive officer&#146;s total direct compensation, as evidenced by the compensation breakdown contained in the Summary Compensation Table that follows. Those awards promote a
commonality of interest between the executive officers and the Company&#146;s stockholders in sustaining and increasing stockholder value. Because the equity awards are typically made on an annual basis to the executive officers, those officers
always have unvested awards outstanding that could decrease significantly in value if the Company&#146;s business is not managed to achieve its long-term goals. Accordingly, the overall compensation structure is not overly-weighted toward near-term
incentives, and the Company has taken what it believes are reasonable steps to protect against the potential of disproportionately large near-term incentives that might encourage excessive risk taking. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Internal Revenue Code Section&nbsp;162(m) </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;162(m) of the Internal Revenue Code disallows a tax deduction to publicly held companies for compensation paid to certain of their executive officers, to the extent that compensation exceeds
$1.0 million per covered officer in any year. The limitation applies only to compensation that is not considered to be performance-based. The stock options granted to our executive officers have been structured with the objective of qualifying those
awards as performance-based compensation. The RSUs awarded to our named executive officers will not qualify as performance-based compensation. In addition, the bonuses provided to our named executive officers under the Incentive Plan and any other
cash incentive programs will not qualify as performance-based compensation for purposes of Section&nbsp;162(m). However, we believe that in establishing the cash and equity incentive compensation programs for our executive officers, the potential
deductibility of the compensation payable under those programs should be only one of a number of relevant factors taken into consideration, and not the sole governing factor. For that reason, we may deem it appropriate to provide one or more
executive officers with the opportunity to earn incentive compensation, whether through cash bonus programs tied to our financial performance or through RSUs tied to the executive officer&#146;s continued service, which may, together with base
salary, exceed in the aggregate the amount deductible by reason of Section&nbsp;162(m) or other provisions of the Internal Revenue Code. We believe it is important to maintain cash and equity incentive compensation at the levels needed to attract
and retain the executive officers essential to our success, even if all or part of that compensation may not be deductible by reason of the Section&nbsp;162(m) limitation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Non-performance-based compensation paid to our executive officers for 2015 exceeded the $1.0 million limit per covered officer. However, we generated a net loss for the year ended December&nbsp;31, 2015
and we expect to incur net losses for the foreseeable future. In addition, as of December&nbsp;31, 2015, the Company had net operating loss carryforwards for federal income tax purposes of approximately $351.3 million that will begin to expire in
2018. These loss carryforwards defer the impact of any deductions that the Company might lose under Section&nbsp;162(m) for one or more of those carryforward years. Accordingly, although tax deductions for some amounts that we paid to our named
executive officers as compensation for 2015 were limited by section 162(m), that limitation did not result in the current payment by us of increased federal income taxes due to our net loss position as well as our net operating loss carryforwards.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Advisory Vote on Executive Compensation </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At the 2014 Annual Meeting we conducted our second advisory vote on executive compensation. At such meeting, approximately 82% of the votes cast on the advisory vote proposal were in favor of our named
executive officer compensation as disclosed in our proxy statement, and as a result our named executive officer compensation was approved. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors and Compensation Committee reviewed the advisory vote results in the
context of our overall compensation philosophy and programs, and based on the level of support, determined that no significant changes to our compensation policies and programs were necessary. The Compensation Committee will continue to take into
account future stockholder advisory votes on executive compensation and other relevant market developments affecting executive officer compensation in order to determine whether any subsequent changes to the our executive compensation programs and
policies would be warranted to reflect any stockholder concerns reflected in those advisory votes or to address market developments. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have determined that our stockholders should vote on a say-on-pay proposal every three years, consistent with the preference expressed by our stockholders at the 2011 Annual Meeting. Accordingly, the
next stockholder advisory vote on executive officer compensation will occur at the 2017 Annual Meeting </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Compensation Table </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain summary information concerning the compensation earned for services rendered in all capacities to
the Company and its subsidiaries for the years ended December&nbsp;31, 2015, 2014 and 2013 by the Company&#146;s President and Chief Executive Officer, the Company&#146;s Executive Vice President and Chief Financial Officer, the Company&#146;s two
other most highly compensated executive officers whose total compensation for the 2015 year was in excess of $100,000 and who were serving as executive officers at the end of that year and one other individual who was an executive officer but whose
employment terminated prior to December&nbsp;31, 2015. No other executive officers who would have otherwise been includable in such table on the basis of total compensation for the 2015 year have been excluded by reason of their termination of
employment or change in executive status during that year. The listed individuals shall be hereinafter referred to as the &#147;named executive officers.&#148; </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($) (3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive
Plan</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (4)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:9pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">675,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,176,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,357,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">344,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,552,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief<BR>Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">650,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,758,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,024,475</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">351,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,784,225</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">640,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">909,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,283,310</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">480,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,312,310</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">352,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">407,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">141,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,316,075</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President<BR>and Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">405,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">527,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">607,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">145,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,685,768</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">424,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,623,078</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">470,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">352,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">407,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">179,775</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,409,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President,<BR>Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">460,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">527,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">607,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">186,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,781,268</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">453,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">424,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">255,094</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,731,672</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">225,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">225,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Research<BR>and Chief Scientific Officer (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">425,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">527,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">607,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">142,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,702,768</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">385,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">424,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">168,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,576,516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, MD,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">450,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">235,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">271,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">135,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,092,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">440,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">351,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">404,895</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">143,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,339,865</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Therapeutic Development<BR>and Chief Medical Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">437,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">278,760</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">393,548</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">186,813</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,296,621</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (c)&nbsp;include amounts deferred under the Company&#146;s 401(k) Plan, a qualified deferred compensation plan under section 401(k) of the
Internal Revenue Code. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (e)&nbsp;reflect the aggregate grant date fair value of the RSUs awarded to the named executive for the applicable year, calculated in accordance
with FASB Accounting Standards Codification Topic 718, or ASC 718, <I>Compensation &#151; Stock Compensation</I>, without taking into account any estimated forfeitures. The assumptions used in the calculation of the grant date fair value of each RSU
award are included in Note 4 of the Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2015, filed with the Securities and Exchange Commission on February&nbsp;18, 2016.
</FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (f)&nbsp;represent the aggregate grant date fair value of the stock option grants for each indicated year in accordance with ASC 718. The
assumptions used in the calculation of the grant date fair values of each option grant are included in Note 4 of the Notes to Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2015, filed with
the Securities and Exchange Commission on February&nbsp;18, 2016. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (g)&nbsp;reflect the cash awards made to the named executive officers under the Company&#146;s non-equity incentive plan that was in effect for
the indicated year. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Gregory&#146;s employment terminated in June 2015. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Grants of Plan-Based Awards </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain summary information concerning each grant of an award made to a named executive officer in the 2015
year under a compensation plan. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:18pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT></TD>

<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="font-size:26px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Potential Payouts Under Non-<BR>Equity<BR>Incentive Plan Awards</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Stock&nbsp;Awards:<BR>Number of<BR>Shares of</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Stock or Units</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#) (6)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other<BR>Option<BR>Awards:<BR>Number&nbsp;of<BR>Securities<BR>Under-<BR>lying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#) (3)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise&nbsp;or&nbsp;Base<BR>Price&nbsp;of&nbsp;Option&nbsp;or</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($/SH)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT><br>
<FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fair</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (1)</B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">283,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">405,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">810,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,176,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,357,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">116,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">166,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">332,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">352,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">407,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Geoffrey M. Nichol, M.B., Ch.&nbsp;B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">148,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">211,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">423,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">352,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">407,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">88,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">157,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">291,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">235,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">271,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">88,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">157,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">291,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The Company was required to achieve the corporate performance objectives at an aggregate rate of at least 70% of for any bonuses to become payable. If the applicable
performance goals were attained at a level between threshold and target, the potential bonus would be in a dollar amount interpolated on a straight line basis between the threshold and the indicated target bonus amount. If performance goal
attainment were above the target level, then the potential bonus would be increased above the indicated target bonus amount to reflect the extent to which the target goals were exceeded as deemed appropriate by the Compensation Committee up to a
maximum of 200% of target. For Drs. Ando and Gregory, 20% of the target bonus payable was conditioned on the achievement of individual performance objectives. The maximum achievement for Drs. Ando and Gregory&#146;s individual performance objectives
was 125% of target, or $39,375. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reflects the potential payouts under the Company&#146;s non-equity incentive plan based on the Company&#146;s attainment of certain research and development,
operational and financial goals at target level and for Drs. Ando and Gregory certain individual goals at target level. For more information regarding the non-equity incentive plan, please see the section entitled &#147;Cash Incentive Bonus for
2015&#148; in the Company&#146;s Compensation Discussion and Analysis. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The reported option was granted under the Company&#146;s 2013 Stock Incentive Plan and will vest and become exercisable in accordance with the following schedule:
twenty-five percent of the option shares will vest and become exercisable on the one year anniversary of the option grant date and the remaining option shares will vest and become exercisable in thirty-six equal monthly installments over the
thirty-six month period measured from the first anniversary of the option grant date, provided the optionee continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The reported stock option and RSU awards granted to Mr.&nbsp;Lanphier will immediately vest in whole or in part on an accelerated basis upon a change in control of the
Company or upon the termination of his employment with the Company under certain circumstances, as described in the section below entitled &#147;Employment Contracts and Change in Control Agreements.&#148; </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The reported stock option and RSU awards granted to Mr.&nbsp;Wolff and Dr.&nbsp;Nichol will immediately vest on an accelerated basis upon the termination of their
employment with the Company in connection with a change in control of the Company, as described under the heading &#147;Employment Contracts and Change in Control Agreements.&#148; </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted under the Company&#146;s 2013 Stock Incentive Plan. The units are structured to vest in three successive equal annual installments over
the 3-year period measured from the grant date, provided the executive officer continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Outstanding Equity Awards at Year-End </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain summary information concerning outstanding equity awards held by the named executive officers as of
December&nbsp;31, 2015.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Underlying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercised</B></FONT>
<br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options (#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Underlying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercised</B></FONT>
<br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options (#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercisable</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Expiration</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>or units</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of stock</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>that</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>have&nbsp;not</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>vested</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value of</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>or</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>units of</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>that</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>have not</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>vested</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($) (7)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:9pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,141,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">83,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">760,830</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">62,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">187,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">228,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">187,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">62,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">342,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">228,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">106,511</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">67,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">112,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">280,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/03/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">342,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">228,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">106,511</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">82,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.94</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">07/10/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Philip D. Gregory, D. Phil. (8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">228,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">152,161</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">69,991</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/05/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/07/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,798</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Each of the options reported above as being wholly or partially unexercisable for the underlying shares of the Company&#146;s common stock will vest and become
exercisable for the total number of shares subject to that option at the time of grant as follows: twenty-five percent of the total number of option shares on the one year anniversary of the option grant date and the balance of the option shares in
thirty-six successive equal monthly installments over the thirty-six month period measured from the first anniversary of the option grant date, provided the optionee continues in the Company&#146;s service through each applicable vesting date.
Accordingly, the vesting schedule for the unexercisable options reported for each named executive officer is determined by applying such vesting schedule to the total number of shares for which each such option was granted. The table below indicates
the total number of shares for which each such reported option was granted and the number of shares for which that option has been exercised prior to January&nbsp;1, 2016. Each option listed below corresponds to the option in the above table that
has an expiration date ten (10)&nbsp;years later than the grant date of the option listed below: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option&nbsp;
Grant</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares
on</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of Option</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercised</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Before</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>January&nbsp;1,</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/08/15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Each of these awards will vest on an accelerated basis upon a change in control of the Company, as described under the heading &#147;Employment Contracts and Change in
Control Agreements&#148;. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Each of these awards will vest on an accelerated basis upon termination of employment with the Company under certain circumstances in connection with a change in
control of the Company, as described under the heading &#147;Employment Contracts and Change in Control Agreements&#148;. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted on December&nbsp;8, 2015. The units are structured to vest in three successive equal annual installments over the 3-year period measured
from the grant date, provided the executive officer continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted on December&nbsp;11, 2014. The units are structured to vest in three successive equal annual installments over the 3-year period
measured from the grant date, provided the executive officer continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents an RSU award granted on December&nbsp;12, 2013. The units are structured to vest in three successive equal annual installments over the 3-year period
measured from the grant date, provided the executive officer continues to provide services to the Company through each applicable vesting date. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on the $9.13 closing price of the Company&#146;s common stock on December&nbsp;31, 2015. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dr.&nbsp;Gregory&#146;s employment terminated in June 2015. All awards subsequently have been canceled and cease to exist as of December&nbsp;31, 2015
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Option Exercises and Stock Vested </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth for each of the named executive officers the number of shares of the Company&#146;s common stock acquired
and the value realized upon the vesting of RSU awards and on each exercise of stock options during the year ended December&nbsp;31, 2015: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares&nbsp;
Acquired</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>on Exercise (#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>on&nbsp;
Exercise&nbsp;($)&nbsp;(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares&nbsp;
vested</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Value&nbsp;
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>shares&nbsp;or&nbsp;units&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>stock that have</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>vested ($) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:9pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,187,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">126,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,127,070</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">799,982</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">346,870</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">377,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Philip D. Gregory, D. Phil.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">230,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,062,272</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">888,141</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value realized is determined by multiplying (i)&nbsp;the amount by which the market price of the common stock on the date of exercise exceeded the exercise price by
(ii)&nbsp;the number of shares for which the options were exercised. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value realized is determined by multiplying the number of shares of common stock vested on the date of vesting by the market price of the common stock on such date.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Pension Benefits </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company does not sponsor a tax-qualified defined benefit retirement plan or a supplemental executive retirement plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Nonqualified Deferred Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company does not sponsor a
nonqualified deferred compensation plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risk Assessment of Compensation Policies and Practices </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s compensation programs throughout the organization are designed to maintain an appropriate balance between long-term and
near-term incentives by utilizing a combination of compensation components, including base salary, annual cash incentive awards, and long-term equity awards. Although not all employees in the organization may have compensation comprised of all three
of those components, the compensation programs are generally structured so that any near-term cash incentives are not likely to constitute the predominant element of an employee&#146;s total compensation. Under the annual cash incentive program, the
target bonuses for the named executive officers range from 35% to 60% of base salary, with a maximum bonus potential set at 200% of the target bonus based on attainment of corporate objectives. 100 percent of the bonus for our named executive
officers (other than Drs. Ando and Gregory) for the 2015 year is tied to corporate performance goals; there are four categories of performance criteria, each with a number of goals that are intended to further the attainment of the Company&#146;s
long term goals and sustain stockholder value, with the bonus potential allocated among the various goals based on the importance of the goal to the Company&#146;s success with a maximum bonus potential of 200% of target bonus. For Drs. Ando and
Gregory, 80% of the bonus was tied to corporate performance goals and 20% tied to a number of individual goals with a maximum bonus potential of 125% based on target allocated to individual goals. We believe this structure based on a number of
different performance measures mitigates any tendency for an executive to focus exclusively on any specific metrics. For this reason, the Company does not believe that its near-term incentive compensation programs are reasonably likely to encourage
excessive risk-taking by the participants in those programs. Each of the named </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
executive officers receives equity compensation in the form of stock options and restricted stock unit awards that derive their value from the market price of the Company&#146;s common stock, and
the value of those awards increase as the price of the common stock appreciates and stockholder value is thereby created. Accordingly, the equity component is structured so as to encourage long-term growth and appreciation in the value of the
Company&#146;s business and stock price. For a discussion of the primary components of the compensation for the Company&#146;s executive officers and the Company&#146;s risk assessment of the compensation programs for its executive officers, please
see the section above entitled &#147;Executive Compensation and Related Information &#151; Compensation Discussion and Analysis&#148; including the section &#147;Allocations between Base Salary, Cash Incentive Bonus and Equity Compensation for
Executives and Risk Taking&#148;. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Employment Contracts and Change in Control Arrangements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Chief Executive Officer Employment Agreement </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In June 2011 the Company entered into an amended and restated employment agreement with Edward&nbsp;O.&nbsp;Lanphier II, our President and Chief Executive Officer. Pursuant to the terms of the agreement,
Mr.&nbsp;Lanphier will receive an annual base salary and a potential cash bonus, each in an amount or at a rate determined annually by the Compensation Committee. In the event (a)&nbsp;Mr.&nbsp;Lanphier terminates his employment due to a material
reduction of his duties, responsibilities or authority, a material reduction in his base salary (except pursuant to certain pay reductions uniformly applied to the Company&#146;s management) or a relocation of his principal place of employment to a
location more than 40 miles from his home and from the Company&#146;s headquarters, (b)&nbsp;Mr.&nbsp;Lanphier is terminated by the Company without cause, or (c)&nbsp;Mr.&nbsp;Lanphier&#146;s employment agreement is not assumed or otherwise
continued in effect by the acquiring entity following a change in control of the Company, he will be entitled to receive the following severance benefits, provided he timely executes a general release of claims against the Company, which becomes
effective and enforceable: (i)&nbsp;a lump sum cash payment in an amount equal to the sum of (a)&nbsp;two times his annual base salary at the rate in effect on his termination date, (b)&nbsp;a prorated portion of Mr.&nbsp;Lanphier&#146;s target
bonus for the year of termination based upon the time elapsed between December&nbsp;31 of the preceding year and his termination date, and (c)&nbsp;his target bonus for the year in which such termination occurs; (ii)&nbsp;reimbursement of his health
care coverage costs under COBRA for a period of twelve months; (iii)&nbsp;an additional twenty-four months of service vesting credit for each of his stock options outstanding at the time of his termination, and all of his vested options will remain
exercisable for up to a three-year period measured from his termination date; and (iv)&nbsp;the Company will provide him with certain information technology services for up to a twenty-four month period. Upon a change in control of the Company all
of Mr.&nbsp;Lanphier&#146;s outstanding stock options will vest in full, and such options will remain exercisable for all the option shares for up to a three-year period measured from the date of the change of control or (if later), his termination
date. Mr.&nbsp;Lanphier&#146;s severance benefits will be subject to reduction to the extent doing so would put him in a better after-tax position after taking into account any excise tax he may incur under Internal Revenue Code Section&nbsp;4999 in
connection with any change in control of the Company or his subsequent termination of employment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Executive Vice President Employment
Agreements </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In November 2007 the Company entered into an employment agreement with H. Ward Wolff, our Executive Vice
President and Chief Financial Officer, which was amended and restated in December 2008 and December 2011 in order to implement technical changes. Pursuant to the terms of the agreement, Mr.&nbsp;Wolff&#146;s annual base salary is set at a minimum of
$375,000, subject to adjustment by the Compensation Committee from time to time, and he is eligible to receive a bonus of up to 40% of his base salary each calendar year. However, the bonus will be payable only upon the achievement of specific
performance criteria to be established by the Compensation Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2011 the Company entered into an employment
agreement with Dr.&nbsp;Geoffrey&nbsp;M. Nichol, our Executive Vice President, Research and Development. Pursuant to the terms of the Employment Agreement, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Dr.&nbsp;Nichol&#146;s annual base salary is set at a minimum of $425,000, subject to adjustment by the Compensation Committee from time to time, and he is eligible to receive a bonus of up to
40% of his base salary for his performance each calendar year. The bonus will be based upon the achievement of specific performance criteria to be established by the Compensation Committee. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of the employment agreements with Mr.&nbsp;Wolff and Dr.&nbsp;Nichol, if the Company terminates
Mr.&nbsp;Wolff&#146;s or Dr.&nbsp;Nichol&#146;s employment without cause, or Mr.&nbsp;Wolff or Dr.&nbsp;Nichol terminates his employment for good reason, within 12 months following a change in control and Mr.&nbsp;Wolff or Dr.&nbsp;Nichol executes a
general release of all claims in favor of the Company, then Mr.&nbsp;Wolff or Dr.&nbsp;Nichol will receive the following severance benefits: (i)&nbsp;a severance payment equal to his annual base salary in effect on his termination date plus his
target bonus for the year in which such termination occurs, (ii)&nbsp;for Mr.&nbsp;Wolff, reimbursement of his health care coverage costs under COBRA for up to twelve months, and for Dr.&nbsp;Nichol, a lump-sum cash payment in the amount of $25,000,
(iii)&nbsp;accelerated vesting of all of his outstanding equity awards and (iv)&nbsp;for Mr.&nbsp;Wolff, a one-year period measured from his termination date to exercise any outstanding options for all the option shares, but in no event will any
such option remain exercisable following the expiration of the maximum option term. If the Company terminates Mr.&nbsp;Wolff&#146;s or Dr.&nbsp;Nichol&#146;s employment without cause, or Mr.&nbsp;Wolff or Dr.&nbsp;Nichol terminates his employment
for good reason, in the absence of a change in control or more than 12 months after a change in control and Mr.&nbsp;Wolff or Dr.&nbsp;Nichol executes a general release of all claims in favor of the Company, then Mr.&nbsp;Wolff or Dr.&nbsp;Nichol
will receive (i)&nbsp;salary continuation payments for a twelve month period following his termination date at his rate of base salary in effect on his termination date and (ii)&nbsp;for Mr.&nbsp;Wolff, reimbursement of his health care coverage
costs under COBRA for up to twelve months, and for Dr.&nbsp;Nichol, a lump-sum cash payment in the amount of $25,000. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>2013 Plan
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee of the Board of Directors, as the administrator of the 2013 Plan, has the authority to
provide that any outstanding options held by the Chief Executive Officer or any other executive officer or any other unvested equity award made to such individual under the 2013 Plan will vest on an accelerated basis in connection with certain
changes in control of the Company or the subsequent termination of the officer&#146;s employment following the change in control event. In addition, all outstanding options and RSUs under the Company&#146;s 2013 Plan will immediately vest upon a
change in control, to the extent not assumed or continued in effect by the successor entity or replaced with an incentive compensation program which preserves the intrinsic value of the award at that time and provides for the subsequent vesting and
concurrent payout of that value in accordance with the pre-existing vesting schedules for those awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs awarded to
Mr.&nbsp;Lanphier on December&nbsp;12, 2013, December&nbsp;11, 2014, and December&nbsp;8, 2015, provide that in the event (a)&nbsp;Mr.&nbsp;Lanphier terminates his employment due to a material reduction of his duties, responsibilities or authority,
a material reduction in his base salary (except pursuant to certain pay reductions uniformly applied to the Company&#146;s management) or a relocation of his principal place of employment to a location more than 40 miles from his home and from the
Company&#146;s headquarters, or (b)&nbsp;Mr.&nbsp;Lanphier is terminated by the Company without cause Mr.&nbsp;Lanphier will receive an additional 24 months of service vesting credit under each outstanding RSU award, and the RSUs that vest as a
result will become issuable at such time. In addition, upon a change in control of the Company all of Mr.&nbsp;Lanphier&#146;s outstanding RSUs under his December&nbsp;12, 2013, December&nbsp;11, 2014, and December&nbsp;8, 2015 award will vest in
full, and will become issuable at such time. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Incentive Compensation Plan </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s Incentive Compensation Plan (the &#147;Incentive Plan&#148;) is a performance-based cash bonus program for the
Company&#146;s executive officers. Pursuant to the terms of the Incentive Plan, should a change in control transaction be consummated prior to the completion of a performance period that has been implemented under the Incentive Plan, then the
performance period will terminate upon the consummation of that change in </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
control and each participant in the Incentive Plan will receive a bonus in the dollar amount previously set by the Compensation Committee at target level attainment of each performance objective;
however such bonus will be pro-rated to reflect each participant&#146;s actual period of service from the start date of the performance period through the effective date of the change in control. Any pro-rated bonus paid pursuant to the terms of the
Incentive Plan will reduce the amount of any severance payable to the participant based on the participant&#146;s target bonus pursuant to the terms of any employment agreement. The 2015 bonus program adopted for the 2015 year under the Incentive
Plan is summarized in detail under the heading &#147;Cash Incentive Bonus for 2015&#148; in the Compensation Discussion and Analysis section of this Proxy Statement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Quantification of Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The charts below quantify the potential
payments our executive officers would receive under various scenarios. The value attributed to the accelerated vesting of equity awards represents the intrinsic value of each stock option or RSU award vesting on an accelerated basis in connection
with the identified triggering event, which is assumed to occur on December&nbsp;31, 2015. The intrinsic value is calculated by multiplying (i)&nbsp;the aggregate number of shares which vest on an accelerated basis by (ii)&nbsp;the amount by which
the $9.13 closing selling price per share of the Company&#146;s common stock on December&nbsp;31, 2015, exceeds the exercise price or other issue price (if any) payable per vested share. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Quantification of Benefits Upon Termination in the Absence of a Change in Control </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the compensation Mr.&nbsp;Lanphier, Mr.&nbsp;Wolff and Dr.&nbsp;Nichol would have each received had their employment terminated in the absence of a change in control of the
Company but under circumstances entitling them to severance benefits under their employment agreements: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Continuation</B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Other&nbsp;Lump-</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Sum
Cash</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Payment</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>COBRA</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Information</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Technology</B></FONT><br>
<FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Services</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">810,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,693</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,070,080</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,693</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B.,Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">470,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Quantification of Benefits Upon a Change in Control </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the compensation Mr.&nbsp;Lanphier would have received pursuant to his employment agreement upon a change in
control of the Company in which his outstanding equity awards and his employment agreement are assumed or otherwise continued in effect. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated&nbsp;Equity</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,269,080</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the value of the accelerated equity the named executive officers are entitled
to receive upon a change in control of the Company in which their outstanding equity awards are not assumed or otherwise continued in effect. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated&nbsp;Equity</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,269,080</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,918,596</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B.,Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,043,336</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,720,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

  <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the cash award each named executive officer would have
received under the Incentive Plan for the 2015 year in connection with a change in control of the Company on the assumed date: </FONT></P>  <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;Plan&nbsp;Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">405,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">166,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B., Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">211,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dale G. Ando, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">157,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Quantification of Benefits Upon Termination in Connection With a Change in Control </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below quantifies the payments Mr.&nbsp;Lanphier, Mr.&nbsp;Wolff and Dr.&nbsp;Nichol would each have received had their
employment terminated in connection with a change in control under circumstances entitling them to severance benefits under their employment agreements. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Continuation</B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Other&nbsp;Lump-</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Sum
Cash</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Payment</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>COBRA</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Information</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Technology</B></FONT><br>
<FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Services</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward O. Lanphier II</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">405,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,269,080</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,693</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">H. Ward Wolff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,918,596</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,693</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey M. Nichol, M.B.,Ch.B.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">470,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,043,336</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The pro-rated bonus paid pursuant to the terms of the Incentive Plan (as quantified in the chart above) will reduce the amount of any severance payable based on the
participant&#146;s target bonus pursuant to the terms of any employment agreement. The amounts reflected in the chart reflect the payments as reduced. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Equity Compensation Plan Information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides
information as of December&nbsp;31, 2015, with respect to the shares of the Company&#146;s common stock that may be issued under the Company&#146;s existing equity compensation plans. There are no outstanding options that the Company has assumed in
connection with its acquisition of other companies, and there are currently no assumed plans under which the Company can grant options. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Column (A)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Column (B)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Column (C)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:49pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan Category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Securities&nbsp;to&nbsp;be</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Issued
Upon</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outstanding&nbsp;Options,</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Restricted&nbsp;Stock&nbsp;Units</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>and Other Rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted&nbsp;Average</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise
Price of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outstanding&nbsp;Options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;
Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Remaining&nbsp;Available&nbsp;for</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Future Issuance Under</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Equity&nbsp;Compensation</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plans</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Excluding
Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Reflected in Column A)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity Compensation Plans Approved by Stockholders&nbsp;(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,008,185</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,800,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)(6)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity Compensation Plans Not Approved by Stockholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,008,185</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,800,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of the 2013 Stock Incentive Plan (the &#147;2013 Plan&#148;) and the 2010 Employee Stock Purchase Plan (the &#147;Purchase Plan&#148;).
</FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 830,817 shares subject to RSUs that will entitle the holder to one share of common stock for each unit that vests over the holder&#146;s period of continued
service with the Company. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excludes purchase rights accruing under the Purchase Plan. Under the Purchase Plan, each eligible employee may purchase up to 2,000&nbsp;shares of
common stock at semi-annual intervals on the last U.S.&nbsp;business day of April and October each year at a purchase price per share equal to 85% of the lower of </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
(i)&nbsp;the closing selling price per share of common stock on the employee&#146;s entry date into the two-year offering period in which that semi-annual purchase date occurs or (ii)&nbsp;the
closing selling price per share on the semi-annual purchase date. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The calculation does not take into account the 830,817 shares of common stock subject to outstanding RSUs. Such shares will be issued at the time the RSUs vest, without
any cash consideration payable for those shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of shares available for future issuance under the Purchase Plan and the 2013 Plan. As of December&nbsp;31, 2015, 1,292,379 shares of common stock were
available for issuance under the Purchase Plan, and 4,508,405 shares of common stock were available for issuance under the 2013 Plan. The 4,508,405 shares available for issuance under the 2013 Plan may be issued upon the exercise of stock options or
stock appreciation rights granted under the plan, or those shares may be issued as stock bonuses or pursuant to restricted stock awards or RSUs which vest upon the attainment of prescribed performance milestones or the completion of designated
service periods. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, the maximum number of shares of common stock reserved for issuance under the 2013 Plan and the Purchase Plan was 19,397,808 shares and
2,100,000 shares, respectively. The number of shares of common stock reserved for issuance under the 2013 Plan is reduced: (i)&nbsp;on a 1-for-1 basis for each share of common stock subject to a stock option grant or stock appreciation right award,
or pursuant to a full-value award made under the plan before June&nbsp;12, 2013, and (ii)&nbsp;by a fixed ratio of 1.33 shares of common stock for each share of common stock issued pursuant to a full-value award made under the plan on or after
June&nbsp;12, 2013. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Compensation Committee Report on Executive Compensation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with
management, and based on such review and such discussions, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis, as contained herein, be included in this Proxy Statement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitted by the Compensation </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Mento </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Larson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Ringo </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Audit Committee Report </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>The information contained in this report shall not be deemed to be &#147;soliciting material&#148; or to be &#147;filed&#148; with the Securities and Exchange Commission, nor shall such information be
incorporated by reference into any future filings with the Securities and Exchange Commission, or subject to the liabilities of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically
incorporates it by reference into a document filed under the Securities Act of 1933, as amended, or Securities Exchange Act of 1934, as amended. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following is the report of the Audit Committee with respect to the Company&#146;s audited financial statements for the fiscal year ended December&nbsp;31, 2015, included in the Annual Report on
Form&nbsp;10-K for that year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal
year ended December&nbsp;31, 2015 with the management of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has discussed with Sangamo&#146;s
independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP, the matters required to be discussed by Public Company Accounting Oversight Board (PCAOB) Auditing Standard No.&nbsp;16, <I>Communications with Audit Committees,&#148;</I> or
any successor standard. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has received the written disclosures and the letter from
Ernst&nbsp;&amp; Young LLP required by applicable requirements of the Public Company Accounting Oversight Board regarding Ernst&nbsp;&amp; Young LLP&#146;s communications with the Audit Committee concerning independence, and has discussed with
Ernst&nbsp;&amp; Young LLP its independence from Sangamo. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the review and discussions referred to above in this
report, the Audit Committee recommended to Sangamo&#146;s Board of Directors that the audited financial statements be included in Sangamo&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2015 for filing with the
Securities and Exchange Commission. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitted by the Audit </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Cleveland </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ms. Parker </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Ramasastry </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition to the indemnification provisions contained in Sangamo&#146;s Restated Certificate of Incorporation, Sangamo has entered into separate indemnification agreements with each of its directors and
officers containing provisions which may require Sangamo, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as officers or directors. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>POLICIES AND PROCEDURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Consistent with the requirement under NASDAQ listing rules, the Audit Committee of the Board of Directors is responsible for reviewing and approving all related party transactions as defined under SEC
rules and regulations. While we do not have a formal written policy or procedure for the review, approval or ratification of related party transactions, the Audit Committee must review the material facts of any such transaction and approve that
transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To identify related party transactions, each year we submit and require our directors and officers to complete
director and officer questionnaires identifying transactions with the Company in which the director or officer or their family members have a conflict of interest. The Company reviews the questionnaire for potential related party transactions. In
addition, at meetings of the Audit Committee, management may recommend related party transactions to the committee, including the material terms of the proposed transactions, for its consideration. In making its decision to approve or ratify a
related party transaction, the Audit Committee will consider all relevant facts and circumstances available to the committee, including factors such as the aggregate value of the transaction, whether the terms of the related party transaction are no
less favorable than terms generally available in an arms&#146; length transaction and the benefit of such transaction to us. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The members of the Board of Directors, the executive officers of the Company and persons who beneficially own more than ten percent of
the outstanding common stock are subject to the reporting requirements of Section&nbsp;16 of the Securities Exchange Act of 1934, as amended, which require them to file reports with respect to their beneficial ownership of the common stock and their
transactions in such common stock. Based upon (i)&nbsp;the copies of Section&nbsp;16 reports which the Company received from such persons for their 2015 year transactions in the common stock and their common stock holdings, and (ii)&nbsp;written
representation that no other reports were required, the Company believes that all reporting requirements under Section&nbsp;16 for such year were met in a timely manner by its directors, executive officers and greater than ten percent beneficial
owners. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31,
2015, has been provided concurrently with the Notice of Annual Meeting and Proxy Statement to all stockholders entitled to notice of and to vote at the Annual Meeting. The Annual Report on Form&nbsp;10-K is not incorporated into this Proxy Statement
and is not considered proxy soliciting material. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">THE BOARD OF DIRECTORS OF </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">SANGAMO BIOSCIENCES, INC. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dated: April 25, 2016 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Appendix A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CERTIFICATE OF AMENDMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OF </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sangamo BioSciences, Inc., a Delaware corporation (the &#147;Corporation&#148;), hereby certifies as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">1. The Board of Directors of the Corporation duly adopted the following resolutions in accordance with the provisions of the General Corporation Law of the State of Delaware, Section&nbsp;242: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RESOLVED,</B> that Article V, Paragraph 4 of the Seventh Amended and Restated Certificate of Incorporation of the Corporation, as
amended from time to time, is hereby amended and restated in its entirety as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vacancies occurring on the Board of
Directors for any reason may be filled by vote of a majority of the remaining members of the Board of Directors, even if less than a quorum, at any meeting of the Board of Directors. A person so elected by the Board of Directors to fill a vacancy
shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director&#146;s successor shall have been duly elected and qualified. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">2. This amendment to the Seventh Amended and Restated Certificate of Incorporation of the Corporation has been duly adopted by the
holders of a majority of the issued and outstanding shares of the Corporation&#146;s common stock in accordance with the provisions of the General Corporation Law of the State of Delaware, Section&nbsp;242, such holders being all of the holders of
the Corporation&#146;s capital stock entitled to vote thereon. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Corporation has caused this Certificate of Amendment of
the Seventh Amended and Restated Certificate of Incorporation to be signed by the Corporation&#146;s President, its authorized officer, on this &nbsp;&nbsp;&nbsp;&nbsp; day of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC.</B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ EDWARD O. LANPHIER
III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;</U></FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name: Edward O. Lanphier III</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title: &nbsp;&nbsp;President and Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-1
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Appendix B </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>AMENDMENT NO.&nbsp;1 TO SECOND AMENDED AND RESTATED BYLAWS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OF
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Article IV, Section&nbsp;13 of the Second Amended and Restated Bylaws of Sangamo Biosciences, Inc. (the &#147;Corporation&#148;) shall be amended and restated in its entirety as follows: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Any and all of the directors may be removed from office at any time, with or without cause, if such removal is approved by the
affirmative vote of the holders of at least a majority of the voting power of the issued and outstanding shares of capital stock of the Corporation then entitled to vote in the election of directors.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Corporation has caused this Amendment No.&nbsp;1 to be signed by the Corporation&#146;s President, its authorized officer, on this
&nbsp;&nbsp;&nbsp;&nbsp; day of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SANGAMO BIOSCIENCES, INC.</B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:<U> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/
EDWARD&nbsp;O.&nbsp;LANPHIER&nbsp;III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name: Edward O. Lanphier III</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title: &nbsp;&nbsp;President and Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-1
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ROWSPAN="13"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g147794pc_pg001a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">


<IMG SRC="g147794pc_pg001b.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Electronic Voting Instructions</B></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Available 24 hours a day, 7 days a week!</B></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Instead of mailing your proxy, you may choose one of the voting methods outlined below to vote your proxy.</P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE BAR.</P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Proxies&nbsp;submitted&nbsp;by&nbsp;the&nbsp;Internet&nbsp;or&nbsp;telephone&nbsp;must&nbsp;be&nbsp;received&nbsp;by
1:00&nbsp;a.m., EST, on June 14, 2016.</B></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="4">


<IMG SRC="g147794pc_pg001c.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Vote by Internet</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#149; Go&nbsp;to&nbsp;<B>www.envisionreports.com/SGMO</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#149; Or&nbsp;scan&nbsp;the&nbsp;QR&nbsp;code&nbsp;with&nbsp;your smartphone</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&#149;&nbsp;Follow&nbsp;the&nbsp;steps&nbsp;outlined&nbsp;on&nbsp;the&nbsp;secure&nbsp;website</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Vote by telephone</B></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.25em; text-indent:-0.63em; font-size:8pt; font-family:Times New Roman">&#149; Call toll free 1-800-652-VOTE (8683) within the USA, US territories &amp; Canada
on a touch tone telephone</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.25em; text-indent:-0.63em; font-size:8pt; font-family:Times New Roman">&#149; Follow the instructions provided by the recorded
message</P></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Using&nbsp;a&nbsp;<B><U>black&nbsp;ink</U>&nbsp;</B>pen,&nbsp;mark&nbsp;your&nbsp;votes&nbsp;with&nbsp;an&nbsp;<B>X&nbsp;</B>as&nbsp;shown&nbsp;in</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">this example.&nbsp;Please do not write outside the designated areas.</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:24pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g147794pc_pg001d.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT> <B>IF YOU HAVE NOT VOTED VIA THE INTERNET <U>OR</U>
TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.</B> <FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT> </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px dotted #000000">&nbsp;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#000000"><FONT COLOR="#ffffff"><B>&nbsp;A&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Proposals &#151; The Board of Directors recommends a vote <U>FOR</U> all the nominees listed and <U>FOR</U> Proposals 2 and 3.</B></TD></TR></TABLE>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="19">To elect eight (8) directors to serve on the Board of Directors for a one-year term ending at the Annual Meeting held in 2017 or until their successors are duly elected and qualified:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:22pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Nominees:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">01&nbsp;-&nbsp;Edward&nbsp;O.&nbsp;Lanphier&nbsp;II</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">04&nbsp;-&nbsp;Stephen&nbsp;G.&nbsp;Dilly,</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;M.B.B.S.,&nbsp;Ph.D.</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">07&nbsp;-&nbsp;Saira&nbsp;Ramasastry</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Against</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstain</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">02&nbsp;-&nbsp;Robert&nbsp;F.&nbsp;Carey</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">05&nbsp;-&nbsp;Steven&nbsp;J.&nbsp;Mento,&nbsp;Ph.D.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">08&nbsp;-&nbsp;William&nbsp;R.&nbsp;Ringo</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Against</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstain</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">03&nbsp;-&nbsp;Paul&nbsp;B.&nbsp;Cleveland</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">06 - H. Stewart Parker</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Against</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstain</B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman"><B>+</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>&nbsp;Against&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Abstain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>&nbsp;Against&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Abstain</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">To approve an amendment to the Company&#146;s Certificate of Incorporation and Bylaws to eliminate the provisions prohibiting removal of directors without cause;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">3.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">To ratify the appointment of Ernst &amp; Young LLP as the Company&#146;s independent registered public accounting firm for the year ending December 31, 2016.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#000000"><FONT COLOR="#ffffff"><B>&nbsp;B&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Non-Voting Items</B></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>Change of Address &#151; </B>Please print new address below.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Meeting&nbsp;Attendance</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1.50pt solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">Mark&nbsp;box&nbsp;to&nbsp;the&nbsp;right&nbsp;if you plan to attend the Annual Meeting.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="98%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" BGCOLOR="#000000"><FONT COLOR="#ffffff"><B>&nbsp;C&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Authorized Signatures &#151; This section must be completed for your vote to be counted. &#151; Date and Sign Below</B></TD></TR></TABLE>
<P STYLE="margin-top:1pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">NOTE: PLEASE SIGN EXACTLY AS NAME APPEARS HEREON. JOINT OWNERS SHOULD EACH SIGN. WHEN SIGNING AS ATTORNEY, EXECUTOR, ADMINISTRATOR, TRUSTEE OR GUARDIAN, GIVE
FULL NAME AND TITLE AS SUCH. </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" NOWRAP>Date (mm/dd/yyyy) &#151; Please print date below.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Signature 1 &#151; Please keep signature within the box.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Signature 2 &#151; Please keep signature within the box.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:24pt">
<TD VALIGN="top" STYLE="BORDER:1.50pt solid #000000; padding-left:8pt"><FONT STYLE="font-size:25pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.50pt solid #000000; BORDER-TOP:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1.50pt solid #000000; BORDER-TOP:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000; BORDER-BOTTOM:1.50pt solid #000000; padding-right:8pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g147794pc_pg001e.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="font-family:Times New Roman; font-size:8pt"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT><B></B><B><FONT STYLE="font-family:Times New Roman; font-size:10pt"> IF YOU HAVE NOT VOTED VIA THE INTERNET <U>OR</U> TELEPHONE, FOLD ALONG THE
PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. </FONT><FONT STYLE="font-family:Times New Roman; font-size:8pt"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#113;</FONT><B></B><B> </B></FONT></B></FONT></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt dashed #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proxy &#151; Sangamo BioSciences, Inc. </B></P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROXY SOLICITED BY THE BOARD OF DIRECTORS
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR THE ANNUAL MEETING OF STOCKHOLDERS, JUNE 14, 2016 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby appoints Edward O. Lanphier II and H. Ward Wolff and each of them, as proxies of the undersigned, with full power of substitution, to
vote all shares of Sangamo BioSciences, Inc. Common Stock which the undersigned is entitled to vote on all matters which may properly come before the 2016 Annual Meeting of Stockholders of Sangamo BioSciences, Inc., to be held at 501 Canal
Boulevard, Richmond, California 94804 on June&nbsp;14, 2016 at 9:00 a.m. PDT or at any postponement or adjournment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE SHARES REPRESENTED BY
THIS PROXY CARD WILL BE VOTED AS SPECIFIED ON THE REVERSE SIDE, BUT IF NO SPECIFICATION IS MADE THEY WILL BE VOTED FOR ALL NOMINEES, FOR PROPOSALS 2 AND 3 AND AT THE DISCRETION OF THE PROXY ON ANY OTHER MATTER THAT MAY PROPERLY COME BEFORE THE
MEETING. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(SEE PROXY STATEMENT FOR DISCUSSION OF ITEMS) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ACCOMPANYING ENVELOPE. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CONTINUED AND TO BE SIGNED ON REVERSE SIDE </B></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g147794g46y86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147794g46y86.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0D44&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              *P   .H    & &< -  V
M 'D .  V     0                         !              #J
M*P                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     !G@    !    <    !4
M  %0   ;D   !EP &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  5 ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MFV9&_P#FOV335U#_ +C?I5\_))*?_]DX0DE-!"$      %4    ! 0    \
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@ *P#J P$1  (1 0,1 ?_=  0
M'O_$ 'P  0 !!0$! 0             )!08'" H$ P(! 0
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M*(OZH;9(<@K,ITT&G\:?G@HUM-4D.B-P8$;B-\:G)I4(CBEB54G)4I#23 '
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M+G0Y1&@)#EV5+4C"2N,.)*P:46 \T/';^L6M>P9>";\UZHZ[R@I4"$)5OU-
MK*+PB:G$]W:T> 3-@>@X2MKLI,5)R_3V$J#!& Q@8LBR&JY_BCT?9\!'2U7O
MVI"O#TG?SE&E%H6=I^B<'(H90%!S[%]>Y97\*DHG%N*[$\3DV*S,HLX* (&
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M9]J_V^&?1_W3_FOVT9^EOT0/UEOMW^6Z)'=_3OYZ?^RSX;V=7X7ZR_N7X/\
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#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g147794pc_pg001a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147794pc_pg001a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ] %W P$1  (1 0,1 ?_$ .,  0 " 04! 0$
M       ("0<#! 4&"@(!"P$!   ' 0$               $"! 4&!P@#"1
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M+R#0XKA7()TW.P;'(1ZHY5 1+Y%SC\O@HK'?$*W3?DY\2'DRU#RQ7E]Z\B^
M](#D5QAW!LE[(S^[:)!+1-FE;=1QO,JHK;)&LM)/7#Q!Q&/UG"1DI84CD S9
MH* :M-?)%D29X[U[;'Z1RC777K-!6P:8Y+6K?NQ%610,_6D4=PWC4-K?.O3#
MO,M$Z[N,>N)C=1(Q8$'J!2_!3T)YJ27EAW47GW^FWX4\IHY4)*RZMVUIR$W
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MA?IFJH&L.<WE8\=UT#W53>T6XU&:AG/Q3D4M,[:L^F9 PHGZE.>1J^R@ _\
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M+[3F]G*;TK>L'D<ZHI'.S.-,Q?VJD6>$E9N/$'B$?%R#E,':XD?B<5#=X&
MKOU121\/M=KFL?U#_D\XFGA&,IJ/:D3S"HT]37K8BT#(UAGMRO6F/BGS 1]!
M5B6OV=\P[!#IZ#HY/@!A#(M^8A%4MQ&T2XX;?J)-+\<HQPY68Z;Y]J:ZKSMP
M)O<O:'(KS2-5<N##W&.L\H,^T,J(_P!XYC=<E H^B*R?C_%R"'ZOC8K6N#Z"
MH[\Y"2+M0"&631;2'%NR/Y1=5(HHBJD#U[WG)W% W42]P=>[)A\Z>2FKX_\
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M82 8"'/L$C1L8P]/VQ^GXX\7IY+/?B$JB'(O]2;Y+.3+,P.ZCI2<Y%!&R_\
M?:C+V;8$=IFL%*O\4TS.ZG5)M4OQZ>FD;H/3\3=7DHM#]/+/_P");S4^5'F2
M!>M7<1NUW$=)B( U;L]L<@$'M2(*P_D*F-)U><P?'^Z0!_ ,-U<2BU?T\5PB
M)OD?YM/*7=C=U<KR]_ETWZQ@ #0-DNFS-]VU-%P8! #(5VG08#T'X H4.G3H
M&&^))10[\.\[-43QQ>>3R76=-9.YWK7EJU?6IM43%.%QV!$6BVV8&[@P@8RI
M[GN"O_@;KZB!0'X@&0'@7(J[4.*:E6\#-&W,QK*LIM'ECY/*/2-<))LS*R<K
M3]8ZFV]KRL042H0AE3!/[)EIH!('0JIRI?B)0Z0IZ/X45Q_%3B5 \<OU'/ C
MBM M&8J<4N#E.#8#Y@!3I3&R4^/.T;->;0Z5(4/46GKUL[UR''X@DJB3J(%#
M)@*. 1;G1M:)S7_5C;WV@X%-UKWB7<KG=+!,G62+%Q;?CIK2 T96E7+U00;(
M(I[2=)N ,8P!VME# /0H] U?5/)0PYWWJV_J$O-/4-"\>';J4T)0E"Z@JEXC
MT55H>&TM3YT9;>_(!PI^1%-C995RJC"**>F:033AD Z*+@7('U.H$7]'BC4N
MMZWI5/UY3HU*&J-#J]?IE6B$.OHQ=<J\2TA(2.2Z_$4V4:Q23+_R%SU4%VG"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A%YP/)[XE=YH[9FO)'XD[^\X]\[&L4]+M2B5]Q$1=$Y2PPI =V69AY
MINXIAMEJ>B0W=+-U8N;722.Y%N](5^,I;YCQ1>:#C2LXUOX3_.9L[9#FVQ_.
MZ[[WUIH[D4.T"/HW:<56+W<Z,HO&3:,ZFA.EE;Q*6VX*/R' #.SH]>@IH)B$
M@%&GXJ*]=/@TAJQH7PG<4[.U1:D9$T?<=X6AP@!2^^E+-.V_8<ZNY4+_ 'UT
M$W7MA$?B4B!2_P#1R=ORJ"H._2U-E8[7/E8\B-H*9S/'1<-F\HN(*',I%0-X
MW_L(3*GZB;WLA8X@Q_CT$4 Z_@&2L\SYJ*[W^CWJC)+7'D Y0V@Q2OIVY:XJ
M;N:7'J=!A7:W:]FVY4ZANIA*Y>WINJIU$.HH@(]<,\RA4;/ ULAA7[/YJ_,W
MLDR)FU"J>RY&NN9$H'*_L6R;):]Y340T74*8/>NCPM7C4RA\3"_*3\#=,@WS
M<BE9X+Z1.\9?"!Y%?(+9S.6^S.05=Y';/C)U8O:Y<PVH*+<X.L2"3@P@L8'V
MUWMB==0'\X*D,'4>F1;HTE%BW]/7$!QL\)GE)YCKJ>UFIN.V^TA9$?@X.WT7
MH-8:^<JQ@ W8:]7E^4! ?\X C^(8;HTE%B#A/%.>/7Z3KG;M5L!V%CY"7V[P
M!)$@B1P^@Y^XZMXW"@"G4#F3*T82H_C_ .5/_P O6 T84\UOYFGCQW_2!(K(
M@+24Y1[:K=VG +^S.Y;7/DC$A$@<?R]Y%J)K6._M 4OAD?!B>:OL\?WC\J.U
M_'3X1AM3AJG6>+9*#S!=5A9F=0UMV!:-77Z=JH*'[@0;D@M@[52G5!4*?U%(
M\B8=.\1"8#0*"J1X>[M@;1Y[/-CSYFSI2E%X:\=]PQS"0*IW,U2:N3IFO4&[
M=SU @?-(_2LT"0%'J;U1Z (CUR4?,2HKSN^/J5\B/+!QRKXS<+->+3>RN<MD
MA)7E+OQO\TC7E,UDXF+78+/2;/L@XFA-<Z\NUEN2[N;.0%)R;2;IL&B:I#J(
MJR"IT"+^A-XB_$;ICQ5Z5<UVONFNPM_;#;1CK=^[7$:5BYL+MB0RC&FTQBJ9
M9>M:SJZRZ@,F?>*[M8QW;LQECE(CZM;3\J@K<LF1,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"*!7/+QN\8
M/(EIV<T]OFM2S!K+6."NK:[:\E J%ZC;M5H:4K]8LJTHW;.&-F6@X6:=-$6L
MTVD616ZYB@D @0Q8$5%"BK^?\..;/CS\1FQ.('$!U#<\;[&+;'INKH_99HK3
M<[4="[0931Y6'9E0FWD'L&Z4"2FGBL8W4?02$@BY(B7T_;)H+PH0V@14&>%S
M9<EP[X ^8#A)S JUOXMWR!TELK=5=^]U7F->DE(:Y:B'2$JWCG]ACVK"9?LK
MJA7F[-)F9T:06G$2-@5'X9*W0$%16;/TT4LLW\./E 8PRPEM</.;CDTF;<2B
M^:N'?%"M$A%0(4WJ *S^*6*E^'4Z1N@_ <,^4HJEZ):GVLOTJVP$ZHJ"+KD'
MY)HN@["<-#?ME:[7Z?4[8SB9 Q.A@3<+:Q8!V&^!D7']ALEKZ/X47INV\-%T
MG^E11CXN7BX^$D_'#KV*C'/NFI$IBX;=K-=%PR:""O8ZDYZWVY</3()E#*J&
MZAU <G_,_@4%6MP^LD0C^D0Y<%@G;=.3B"<BJW9_34(FHC,3NW(90K1R(G 1
M<.ZK9&':7^\=-8@  ]0ZRCY%'S75=L3U:@_T=NFF$1)QZBUGN-3@'Y&SE$ZA
MK2OS$LUBG(MR0AC&+(LT(E4QTC=#^FEW=.WH.1_,3S77>5_(C2^\_P!)WQ^C
MJC9XIM8M,;!XYZ&NE5,Z11E(;:>OYUTVE8E\T-V' 9ZGD4L;0X!VKQZQ5 -U
M*H!1^1/-7:^*#R3CN[P[QC[BYI396W.2W#S0&O\ 2BFF58/Z>CK[M*O55E3*
M8^J6PIY6(H-@IDPM&DDY)1O(^]B&*:Q'*!%O0!>+3Z?M4%&[PM>"#D/QL+R'
MV/SWV77IR.Y?Z\L5$W=Q#K)F=NI]T8VR1DI5_,;<OHD#W%GC7$Y)%:-ZVJ5%
M LFOWR+D#>F4UM/%%Z8]$<=]&<8-?1NJN/6J*+IW7L2(J-*M0J^P@8Y1T<I2
MK2,@+1(KF7EG($#UGCM1=TMT 3J&')Z4\$69<(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(NF;!
MUSK_ &S3I[7NT:35-BT2T,3QECIUV@(NSUF<CU#IJF:2D+,M7D>]1!9$BA04
M3-VJ$*<.AB@($57J7A)X-TW7/)[6G'>(VGQ/@^7%"C=>;=+Q_P!K6J"9N8:+
MESRB2]?K5M=7*GUQ^]9NGD4Z4:1Z0JPLB[9E["+")9=H\D40-'?IN^.6I..?
M)CB)9.0^]]L<<^13FJ6II1K2UU_&26HMO4IP0\!N375C@ZRV.RN1(]LW9.DU
M&PQ[]FW(DY05)\,!@I3R10+;_I(G,LK5Z)L+R<;YN'':FR?O:[J8E$,U^2LU
M7)EW;.M)S.T++K^IR+@JZH"^:5T>ASF." "80R79]NBC56-V3].OQD:<<^0G
M%'1V_>2^BM"\C[?IJ\W'6L5:Z]>ZU%6+48N#.GD!]<5Z2GT"['<-XI><36D%
MDU5H1IZ14DB D$VT4HH+7UY^G)X9UCAO(\(;UM?D[M+3TEOV(Y(^C*[%@ZJZ
MB-C15,?T=0*^A4*C%LHZOR\5(G6>M%".!6>$37!0ARB)H;!2B*<7&SQ$^.SB
MMK"7U'K3C#K^:I]DM5<O=I0VVS5W.[LMWJ$?+Q-7MDFKLY6SMTIJ BYYZW9G
M:)-B-TG:P)E+ZI^Z(: BL/A(*$K,2Q@:Y#Q5?@XM K6,AH2/:143'-2=1(V8
MQS!%!FT0((CT(F0I0Z_ADR+E<(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBA;SCY273BIKS6$]K?4D7
MNO8.W^06JN/5+I$WL0-60JECVJ]DF,;*2]S&HW<8Z/CU8_JH 1RIC@?X"'3X
MP)HBPA]__*__ "XN.7]0A?\ A/R%7?!$^_\ Y7_Y<7'+^H0O_"?BKO@B??\
M\K_\N+CE_4(7_A/Q5WP1/O\ ^5_^7%QR_J$+_P )^*N^")]__*__ "XN.7]0
MA?\ A/Q5WP1/O_Y7_P"7%QR_J$+_ ,)^*N^")]__ "O_ ,N+CE_4(7_A/Q5W
MP1/O_P"5_P#EQ<<OZA"_\)^*N^")]_\ RO\ \N+CE_4(7_A/Q5WP1/O_ .5_
M^7%QR_J$+_PGXJ[X(GW_ /*__+BXY?U"%_X3\5=\$3[_ /E?_EQ<<OZA"_\
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M"N?E@95.)KT-%CXX:(L=I7&$9&L3.#UKER"JRJ$6DB@9P8I2@)C!WB4"AUZ
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M7S:J0DY6Z/-;A\L;RSP%2EI)A0-5C%.I^*A9!ZS,'%YVJ'L5I)NLN@ +%*8
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MFGOBXXU.YB#*_+"2SKGU%N)*'+*(IMY,L6_5XO'=1Y9%!$A%P1.3UB$ I^H
M 8J?@BX4-E^3$IYI0OB:XH%4LK.4C[&<.<U< \^PG';I_-,9HP<5^LJSF'SY
M==TDOZA'"RQSJ 8QS"+7X(M4NTO)N1$6Q?$_Q4*W--1=D,@7G57P1-8H1%@V
MA9X4@XL=@S40WBFJ;5UT]=N1LD5,Q03( -?@BX<UQ\C!Y*T3)_$'P\-,7?V
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MKJ>YBL+5MM;"1Y<(+=KY)6PQ D[(Q)+(\,% '/<::E=@,H0H]#'(4>G7H8P
M/3^WH(_AGE0JUAKCJ 2OSUDO_.I__#+_ .WD:%1V/^!_N+]*HF8>A3D,/]A3
M%$?_ & '%"A:X"I!HOO(*5,(F$3")A$PB@ER'W%M*M;QJ.LZ399VL0LCK)]<
MWSJJ\=K;R EG4J2X,J^BC)-ZM)LQJD.BT6$P.%TQ(LH)@ X>F(#D.,L;26P?
M=W#&O>)0T!TS813;70N!W'[!Y+I#M;P/AN7[=WW+N0VEM>9"++LM6-N<Y;86
M)L9M7SDQNN(W>YE+@ 6,<"UH'I.X$=/7Y;[$B-O;$U=/L*NR2+R,U30]/S9&
MKL?JNBOYW2];W% 22!GOIDO517V,61;*)F*FK&R:)RHG]BZ$?<86V?917<9>
M3[61\@_BO#971.&GR.V;3\"TZ^H*_1]D.+7W!L5S'&27DCSQ3(WF3B+F_P!&
MO&0Y6?%S,.RIL[D6)@D:02VXMWM+V^XA ZO5N4^[:;1:CN#9<I3-@4_9='Y
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MQ:/CS*%-Z7P$@X&"6"ZFMA(X,:-FTA[6N;&)9VN>T4<& EC7"E33Q4UQ^'S
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M[%R6OR_M./T^D#7]F^KU5/YNAV^52^G-W?O?^]2B?M/]"_W02?[K^W(?]O\
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MJQ3BV*=+3EN!-QLRU4++R 5E6QH<@:9&(6%2!!Q\J4G$8QPHW([%(7!4#F3
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MT-R(V7%1$>#V2<.7/LHJ+9I-FR7=V(-TB)D I"@ 9!R:**'*;(6M:SH0&@
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MZ_"[&<-(: C5)!PX.QAHEJ )-6J0E0;IAVIE*'PS(^211136@B:UH=C[=QH
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M @@$$?:#H5T%^%+%8S-?B.X9B<S;07>*N,[;LEAGC9+%*PDU9)'(',>T^;7
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M^ E-;Q_\5)34W(V)N3SC"GJQ%M5+6Q"W!QIJVL!;G?LT42L@MD3S/W<\0%\
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M\6'X;99S!VA@O.3.=F61&XL[:_LIA?Y_#Y&"4LN6S02-DLK2:5KW1N,<ABH
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M9J6)S,-G;#&6QD;;6KRZ2WNG"1TQ:]@=*!L<P,8#5CJ5K?XY.''_  <\:_\
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MLE)M\P^>..GJAA<^".=X<.F^[MFT/5J(\QW-C51Z06R/M/;?K,9:*?7-A42
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*1,(F$3")A%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g147794pc_pg001b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147794pc_pg001b.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ BP$3 P$1  (1 0,1 ?_$ -,  0 " @,! 0$
M       '" 0& @4) P$* 0$  04! 0$             ! (#!08'" $)$
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MQQO6U_2)T5NMIN<R9&N!>BS=MM-TEK'=N>YIUKEU[O$JB1VTH/R' 7!Q)&+
M4?OPW$3REXU-Y \14U^=)%L&;E1J:*)$R?*3<$E3G64$*8"C@"8M$9GI!8].
MC_\ 9QG6+E;?MK,K12%Y0W+/B/:SX/\ 1[?AQS'J'Z;>EFW-_2]O6QB:+:S$
MWDXD*DJ4K-95*$ YBFM$ >\'XWVD8I^/Y5=X 6V5*?(8)SFEI^.-8C%B!-^
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ML%?::8C_ &\?(?N9L?<0W5O)WJ('1@^:;#F0\E'#T:-6-OO_ &JV!;-C@ K
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MQH9]5J"]N)WR/]?7N[W"G-_,>:PVHNE\Q[S0T\^?N:E<N5%*FM-??"^=!6^
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MU<RQQ+H20"@G%@K[^2)@HEWMYI6U.^2,52L<A>U2A+*6YO+>@1^F*YN(PA.
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M;;C^[17O^9?Q-?Z=1;6&G?7U?D+A_OG'&.JW^+=T_8_4C]-D8H*L_P!]*_\
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MAQ"E"M*< #\1^[C3.IWJ%Z4[EZ26K:EHGO.7R+M2T07$&,^D"1$O;4U]&=2
MDA,=*EA8)2H@(22HTQ ;9\=6[-,X[7U!T"9 E5FXM2B8"#.HD/MQ278;2M&G
MY)QATP)?PV3#7%%CD8'G)1(5'IR3 CSD7MRVA?,97#[PFG=5[9+[GP?>+2>/
MPD=HICIDSU4]$GHV\&V[G(*[NTZF+]#DC.5;QNUW37W?<K E,.]^E%*+7SB2
MG$E;;-ANYRN=NAE>RR$M""5"@VQ-D"A)F<77%9<:0WF65<%D$Y6HW$Y'@+-
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MZ>-L+FLQY-[F(8W!*CQ]OJY1OW[DNVQKDTJXCF/HR$<[$A.Z!D$/K=<3F:9
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MW$M0O".RG*8TM7,8@9;8T$IQ*(Z7'9HN@#&ZJ5!J@*E ,I4F+*/">4<GK=W
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M82]IW9#Z&K>D-:RY 6R^U'4@XD_:[;<DO2BX):<LB9D*?96D<5*MA$8@-))
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M.%8OPKI=H=7B5I94!U?3._TRLNPI6@E@0'K7@Y(M>'-4QIU"8);8<ZJ,#$I
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I#7[=WG-R.;S.37DJ<I7677ELO=T?Y/+W<M,O"F).U$QI^&F&&F&/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g147794pc_pg001c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147794pc_pg001c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .@ Z P$1  (1 0,1 ?_$ ,8   (# 0$!
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M!6< 891;E\-4W35HSS2"UE*7^(26#.93"2HN]B23,QZ8V=S 1Y(,E'J3#TN
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MKC\>Z'E!O8DM%M0J04G3?2=%].](]6]BH+LK)XO(M=K=V,76C%(X_L4KC[!
M7>1)V]HK:ODYS#)) _O@V$;2202N,,(]_ <9-+#VSG*2Y/DSI+;C(H\A"4GP
M-:$=>H %54Z>W5&7.XSG;N%YCQ7(^)H<R+RG8\51;I+[+T9YZ8TPI;DZ:H/,
M,LLA[U5+4R$KV5(0HUIK*Q^:!Y)/Q3YS_;4!^V[IV_;-H]J?THULY_?G[3OZ
M:V[]RF?R;3Q..N):]Q;C9KN&;)4&_N$FV2O2QM<6V4,E+LKW8\45V3\6S-$F
M6OLB9A.<6:&).<8:G=!A4%HC@@$$L6,=ND&X2)*KF7(SAV-C=0E5#M430@>1
MIYT%//6=G=-?.4+SW976_P#$^31FK1B>.P;XY'=NKS4&2F!M=<CI98=].0X\
MH!*XX*"ZDJ!6FM=!:Q:ST*UPG$HH@RY.9=*.KG4^)#(K9T)/@A0D. "R&*GM
MT?;D)K1CW?L8BB"P9]<XQV]>O)>E2FROTXWO#QH[7J!YBHK0^7@>GEI_XMEW
M<GROCL/D=-AX%6F\,)D@SFU"8=_\8"WG%!WI[P4M1'F=6*V8V'IO<2)4ZS7(
M\697&D:6QZU@5<NJ E-"=TR=K&M(Y,S#))>V2I:[L2*C,P]X6*#WXE,%7AZ*
M+["QC L=!Q&GHI<<92%2RFI!"MFPKH0  %!6X)IU^C4^'746\1\79YP3>[]/
MP)BT77N$<M4^9.;652\5..N+;=>8C.1T-/*N_P 4TTA$-:RT8BEU!)!T,G79
MS6ZO_OV..BZ6"W[#IQ!]S:%Q>]:%AB"R]@+$:S"S9X\.UUVH)6I9I(]-CJJ3
M(F@[+9@!:$!Y&08$7Y==B+(4VS.:HEP[@4JW;0-J4]  2*]:U/4T/MT[H?$/
M+&3#C[NHP"58[7GCOQ\J19[S*<@66"X*0VF[5;@D.L-.-I<=DI]>JG2TYN(5
M35"ZBV.X^Z6W43RO+AM1;U!EZVOE48+OJ-Q6P+9B%G+9/@IL10QJ6FI6YA98
MRRI"Q-PRP!4(G TX("_$72J]%N+\#H&T/>KN]W> 10>-:DU-:^7AYZLKG'%/
M<[G_ &_*LH:PVQ<E'+&;E6SOR85ME6],>KBY3B0IQYV0ZI0?"B4.LI;*E5&O
M;R)[%P::T-J?76LV-TC3-9'VUY Y6OL#'WUJGX"IPN:W9"XGV"W'@..5-RO"
MA.69XI<)D99)>,Y[= VJ.6W7%2?3HI*0  JGNI*?K >/2IKU))T6[6.*\BQ_
MDG-<IY<_F $9?&MK+=MLKS3D(F&AQI:!"<30)<3L6H5<]1U3BB!75^X71F;.
M'K)QWS.SK;FM7;<ZK0W>F9SB8S@^16Q&;@;HZG,;HM!)2\(E[0Q5AA:TEFB0
MGMBU;@9IH@K,9%WPGNO!EQR<VA*5M.J0 *T(2I%">M:]?(@?)JLV0<BC#QEW
M=)8+19+?F&#YG*Q"+$BQ Q;9%L6^0N1,CM+0Z]<-KJDAY$AIJB4 L$#K7O\
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M*V5-A1%):75;D>K.7.;@B,7G^>09-"$..PMQ2I<E;6WT8I6222#N)6D%74U
M\":'P'05Z%S\^X-E5_S"]XC-MDCB_MPEWF5.N<ZX S85VO")3I9G)=523&-Q
M;#26H[+J64;:A!)-;U?>>\N'_:RQ?DHUGT4^-M7\4'Z=7W]5S_MV[(/_ $M)
M_K'</OZ2746IUJ[E<.5$UI2Q\'-ED5VTLF;/"*7S-IB993"!DDK'[Q)K@(7O
M'B7NY.,%]L9R#.1?)CI==FMP+VX\Z#M**>!_")\@=:#YOS7AG G?ADF6Y^BX
MBRS<)@Q&EQHKDDEXO,/4(0.@V-*Z^V@\]2)%I=<^E'%3R1L-XG5\F<K*4:YN
M$431">,\M-5D1FTFLAW^(+09 ),,D3L1D&/G9&'(L]L8#GN$]/:N%Q:6T#[J
M7:]#YM]/$#V'25)Y^P+N"[SN*+EQVFZ*B6E%]1)5)ANQ@DR+<X6MI7]*OI+K
MX4.T=2K34]V6K7G;ZB6W2>8RZPXY:U,:NL.ZZ B+-"(II7M$)KAXB[4A<7]X
M;7-O-3+'.1]CTI(2E60AP(!H<8%W3H"Y,.69C826EN^F:U^LNO3Y?=/WO#5,
M^WR9RCP9R0]W!6&#:Y>%W_,7L46J0ZLN(=ESVI#BT,M+;6%);8]QQ14W4D*0
M21I?7$#%(O:\>J&*,<9C^S46;"BT^RT9VX9V^11_7%.XFS%5"B=,F:3)36Y6
M3/E*%09+ IRU 0C;T(A^&1!Z.79]Y%7#^PK--I;JG=[@)WD#KM) 3U\"KJ:4
MU9[OGO5YPNZ7R]W&7)Q"\O**K#(QIU;#]]4A,5,LY2['4%I,)*VTVTK4@D/2
M0G<$G44K1155+:=;)SO&MVO5CR*0\I]AZXMZZQZQCSZJAL F"9J0E AZW",E
M<SFQ?(<F-A #,(TQ@Q"P5GOVZ[><D.R&4AUU(#"5=%$5/JE)K[>A_0&EG+D9
MIG_.V)XX<LRBU6N+PW!OBT0;@^RF5,BK<43*1N*'1(KMD+*?5<2 -XUP]H>/
M+5'C%V$TML97(+%NBMW>TI&;<\6G4<B5BITD5BS2QJTI8XBP19N"O"YFOHO,
ME8 T!H2\9 'YN>_4>ZSKC$<;^BM*10C<"?=7[*GQ \-*/#W='S5W>\79_BK,
M:UV#+&+,P+5(AOR8*E2)#CR5'XEZ0LH],,BBVBDI*B%'J*,$B_'6S.I[L\ZS
M.!U=ZY;"M;SM"X;'0I='JZVOIV53!&.2L%!UOEB96U3$:7.CV4 %K.<4(\D1
MQQ0S ^&,=)[UR>]1*97O/M^YM/O(.TH%2#4$FBJJKY"@->E8;QW37"&ABW\N
MM)NO*N+O-8^BQRT/SL<N<>*L,/7F=ZSKB9-U#WK%J4E00H(;6E)W'64#[]'<
M3\:_93_7.S_MHZ?'P,+]I:_2)^]K:W^P#@C^A6)?]HM_\GU6CHV?'4MZ^1?4
MB^MS^MGH)W\4O_5/W#KVME3[^'Q<7Z#-;^[0=,='\#3^7I^ZO6"MM_PU6+_,
M6C]?H':Z_O7_ )TOKML/E^L*^3KE?XB9\S/[VK4A<I?2[J/FQO\ 7:"4A_ (
MNO\ 3FK_ .';>C/_ #;7Y*G]^U(5L_Q*8_\ Y=4?K].2T\_Y<.5S^I-4/]L<
M=)<W_I,3YE_JU:H;SO\ X(.%ORC(_P#R!U'N*7^B>4G](#LU_%$'0EX^G%_)
:V_N#2IWH_P /X;_^8X_^J7K")U(NOI%U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g147794pc_pg001d.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147794pc_pg001d.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (@+& P$1  (1 0,1 ?_$ +X  0 ! P4! 0
M       ( 08) @,$!0<*"P$!  $% 0$!              $" P4&" <$"1
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M 'U.MR[\O_*CN1IE;U/T1/+*P!]3K<N_+_RH[D:96]3]$3RRL ?4ZW+OR_\
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MY>W/?-SVK;MML[=MZUD^UB023[F6O$MM;W$D3Q;G*PNCI*USZN:R_P#.O/\
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MK^Q/;7<61BGL,8+'IU;J^N2V\=NQ.*:3QH3HVIN),18_D/WDM<S0DU(:1<>
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MAX>< @F"EM,QIZ*%NY9XGKLM]\FL%_QUR5QP;&O;%8I"=<+&>9F6ZE+X-+D
MYM9L)>)08U.253'UI+Q\T<B#0)HCTQ!G&E =(BKOV1=;E?M]XY8Z2/8ZQ(@4
M 7S*RA&XC/I//TEQ^%PE]Q'YYM:Z2=]E%U5BQO"V/AK^^-Z>B@!R8I$(@@LB
MA?5AY:BT"@]JHHM9:N&+>+65>[W",S,?UTI<<JL<[21';M):;&.D^9)-"&*R
M[C;YGL;9-9'XZYM=NW^'W3JWFU3)JM]$WR=#:#I4)03(- 352HL;@EF+I3"R
MVW?86MDIS=_*W!3;UCMT]QE2P2%ZCRY9BF2H@ZY3BG*GIN*-%+ID]IV\Y31N
MZPY0C)(-,"6/K1<D'$4]P,44P]V:X:B*BQHS4P@8CCX5N78.RS;19T;$W59?
MX>=+EGQITQX,<&@!9(FMU@[>Y/C+5)4(3$HVX1(:< :EQ]QZ$41?1N+%EGC.
M#BW"F!*$S*U->*;OC5%U]*]0D2J#+4+;>I'@\8.'5E*G9156>.G37K!B_&NJ
MZ844+Y\L1-V9XQCPTQ9V](/C3=:;;GUGG>%8L/6+LH@DZC$7+0QR8GM$BNFY
M70;FM2S(X&.!UJN(7%"." \?6FEB1 J:.D&@I[J5"/>"NJ7-+C[G-JE<;MS8
MV<P^Y^/:YMME"<2'>X%]\P8M%OX#=%63,YR<<$3B5;VUT%:0FDI1,Q* 8RDY
M"-0<+Y@P!D.]T65.SU@FZ[N;N_7-8_!6)ZOH.VMAHICK<9YCJ)6^QB23?#-_
M3H%]N90YHQJ&!R=WQ2D+/6MYQ1HJ4  P?+3AJ:?<5"QC8KS[&B7S'_3LVILW
M9B11#('%Z\[U;?+IT463DD(602?&6_?"GN#W!G"^-MR.3R:4S%E6OI!7SBP:
M5*6,9G4"-ZNL C#JI7V]:N*$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T
M1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$4$-S"WTUN'A;=:E
MMF)7*[@6Q>;4Y#1&'( 5-7S1TQQNS"KV'PYO)IQJH<Y,T0A4C2%<*]:K-*!3
MIKJ'"H12SM;=F 7YMK!;V6JD**5VWNI&6N<0R0-YM#4Z]E?2**R2S:4_63.3
M<:(:5:G'0)R580:28$)A8@TGUQ10!W+6U$0V8>N"1N1DN#GN#XLU=5Z9$06N
M<0-JZ0D(/WDL**"I6%MZ<8@$]:(5"0"K0'+2M:5W+B#W%]^QQ)8W:KF@K@*A
MM:#VK[T]?==K_#&\N9+SR':3S2.M(/$O)M)CGN+(S(R!S]-A.5AD< 7Y "\@
M%U2%$S<ES,M/)LA6S"*Z=R'RUV.\7"SR[)N21R.R>126XBRM&V3QZQT>!&V]
M>>SLZQ,H2*G9<*@0B&+DXU$GH4HR_%>/WT6U.Y#:0MFW%X+8&N+0U@Q:Z4YC
MB<" .G_55OO?PV^.G/-E\23?)?@VS6N^>7;XRVO'+>XN+:WMMO9_J6UQO5P;
MB1C9I6.;+':PBI &:E)B^+G[C.1^-DXMD[64DK#<V&2N,VRMI>_"1P:FEX,B
MEYI3)F=K_@%M88HA:G)$Y)HH:<F1+FJ0$T"72IU0%T,+!S6^,;3NUO=B_A?$
M^-TLD5T"1FC#2[/5Q(J74+@6?\M3T^3X?>'?,O&>:V_DG9KO9=QV*]WK<=FY
ME'++"+K:+:VEE_.DGNGRQOC== 230W5@^KJ1YGY'NI&W<"MUG"; [P7^O!;6
MUKO%I-:#%VW2>0G3"J:86H3)9-;653=DBT!0FT(2KIO>XP0'@TT AEHB0A+Y
M"BZ4UF>+W7'Q>P;9M\LHD9/<OI3[9/MD:PN<6XAL7\M'"IQ-2O9?B=S#XRQ\
MJX]XH\>[SOEOOEER#DNX.@%IFM-T<ZVW&ULIKF^>,SV6>S &T:T@.F>7/S2.
MJOI!M^KFJ^"P];<EF9([<%7'&D^:,,:<37>/,\C,2%B=&]E=#AF&N#:F4<0E
M&B$*HP]/&OXZ\GN6P-N'MM7.=;!QREPH2/8D88_L/X+\<^66_&[7E&XVW#;F
MYO.)QWDK;.>YC$5Q+;AQTY)H@ (Y'-Q<T  'V"Q2[BYN"A%WHE_G5MO.%%%F
M/]PDELKHF+9*;;0+PG7."H<$;FB)JJKP76"I445HE"@FB7D.("(0J\G)NG%A
MR V3_P"A2Q"ERS4C(;GH<OWDNPR&@%!C4.I[U[M^($?RAE\?7_\ ZV[QMC-/
MEE@_<ML#+<;CHN9&T7LDMTW3.UY6Z4T<;S)5DI  S9L:KA;Z(1FN#ER-QU+-
MR+4RG!B<6Y-<EO\ '!)Z">Q>63&4VFC\O'&*@>RGG^ WUJ4-Z=7T5<22!FA_
M\N94&VQWEQ(+^SXJ8_RV;@QY!+,6N;&V0C-A_.'AQ'M4#^85[.M.6\@WH>3N
M'?#Q^V.YW8^3[+<!&S\(M?8W-K:6VZ3VHN:PF'\Z"ZCN)(O2W?*UA_U6!TTZ
M5NG<+"/;!QRO$)X,?LCKRP1HN65(Z*QOKM9:V;F^W%0M,AJKK16)2\1-K8J&
M_,5J8,L%.?B*HM:]6RM.0;MNEA_]5M XQD4PF>T-)PPP=G! PJ5S;_X-Q+Y+
M^;?,/CP6XVKAW'+V7;C;Y!!%O&XQP6#Y;?+]@;#=27N7)]H<3EH*+E;H=+0.
M^2]JF;+AUDD QG28U7A<8!,X4WKTB]POTO<*HSX:MD3$T.+H%(&(HTYB5H&(
MM J/&"AP1 ,'33B O&;3,_9@V3=C=QA[7.H!" *.H2!7.2*^M*TQ *L?"(^0
M=O\ #&^[CX!@L]V\TR<SVF.^L[R1CF1['&S.V[9;SRQQ%_Y;Y&R78#IXF!VF
M0YC5D9P#<;ANN%^-RVZC0!BFE;9M:96VA:$[ ,ID;U:YOAJ@]D2)D:9L5+X:
ME0'F% )*ISF5%R!J*M-:KR5MJW?KH6;BZ#5K4FOW$ OQJ?1Y</4]%Q]\K;/B
M-C\C^96W!K@W7&QO4KF2:KIP9I&LDNVMF<Y[I&LNW3L:XO<:-IF( *CAN/.U
MKH)+,7KIS*[=T\:IG&I)<5DA&24$@C3<.*0M"^18BLJAMPV!T&HZVDX0$!+9
MA%HU=2UA1@Q!H (Q!RO%6W4\-W:0PPW5L]L9? ]Y8Y]''*YCAZ93BZKFU^T5
MK0'V/X=V'-^4;#S?@W'=@V/F?'+VRV^:]X]?7TMA=7CX;EWXMY83Q!M/PI'%
MUV'31!T3F-!+BT'&=8%F%BS'=M?*Z\(I7'+,MU^,OGN22>3M+FN>XW&;WQQ$
MU6MDTQ0M"!2L*.F)49&JZP!%*&4.H((> PTKMVXRC=W;OLED&.OG6]L&M:0&
MDQ/<^0 N(IES $$X'!=H^5MQ'G+=_,O@CQZ+"\\C3<6XI#;VUM+&R&XN=FN'
MR[G;6CY7M81:&Y$64O):6%I-6N(F)CE#E*3:;R.FS['#$*RXD9S5NQ"/WVT@
M*?FR(W!99"F:5B+YHCYYL#)&EJ"=_95!\RE-!6O, 5..!W";_P UM+:-]6Q2
MVS'T.!<UX=C['*74Q]""/4+GCS!R&&?YZ<.XUMEX);;:+WAVUWNC*3!)=V$T
M#I6/RNR2&WEE+/NKIRL<!1S33H;T9K+<3=N?":'0]^+B=TK[V.MA%V2;*VUS
M=D=JX@WPN+)YG<T]H:D:UP<W5A*>20-J8LDPRJH8C@@'4BA8[]CQ[^M\KW&>
M5FI:6US(XMJ!J.+W%C*D@ '*<V(]A4!U1E?''QLMO/7S \E<BY#:F_X/Q;D^
MY7,UFR2.)^YW<EY<NL]M;+*]D<<4YA>ZXD<]K=,",N:)2]L_-O-7CP/%R'L^
M,<F?9M;J+NS\QNLTE#"]QV12^X8S4KW.),\H'],E7U6/+D\!.I6E!%%E5 2
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g147794pc_pg001e.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147794pc_pg001e.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 10+& P$1  (1 0,1 ?_$ -P  0 " P$! 0$! 0
M       '"04&" H$ P$""P$!  $$ P$               8$!0<( @,) 1
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MTNW0D<A363,B2W[W#;@-BD*:RQXY6I><*\,8QGDURVR8V-RL/'I>6I,DN7)
MX:$@BW#RDV/#A6^_5?P"[-Z>=:>G_2Z%G\G(@;QD3FWWULL!R.(C;*T%I*>Z
MHK+A"M?8 "+WM5@.U^ZUMUYZ:L/O)"I%<(7"3IC4VSUT642)MUI!#8DREQB
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MMD9Y+RRX6$+TV%KJ"21V7L"?/_X5\W+X$MH8/PF-^(IG/9)S-+VY!R7LBF6
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M"_;VU3=#_ 7L[JMX?W^L>1S^3B9-E.4/L[;+"FC\GN/H1WE=_P"$#0*NRQ)
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M<9VT>IFS^EL;*1Y^;W3$QZENLI"F(LJ9/D0'8Z'$N*$E$1UA25OI*$N*2O0
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MV&>[""0O6KF\P-\PDI1I)TV5;4>8]^=F^WNGMG:_I@;KQHRSUS<VVY6J=46
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MP+E(/EMYAY?<J8=/\7M3-[UQF'WS/=Q6T94MMJ5,;;YJHS2SI+W+_*2V2%+
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M,[;Z] 79@*W56W!HDJ+9RQ=V_P"N#7PNJQ=G$CMO-5DK*?&2<"&;A/I4B>F
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MME!<022P' A1 2Z=3"5*42@Y%.Z=)$#2=*9&SI O.6**^RY1BZ]<0Y#I2QU
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MMWUT!@N/%,6 I[6!@?996%L^SQYEY2KS8\OAGFE1)XTKV-\YU\KAOU,?P_\
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M4/#+-SK3E!,9CXBQ)2GG45*PE'&L9\N,2VV,^./^LF\8J;&B-OM2@HMNI2+
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M7GIF?LG]=_YH_P#N<2IKVO\ CY=8_N9W+^>[AY01/F!)^.#]16/=E?=I;O\
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M1Z8:7W7V@T*%Z>W/KCU,-'Z5J3KI;1V[K/K.J5G75VKVN9VV+CO"SU0-,(H
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MEU3)2TXRXF4IQU!!1'$4O>TGB"QS$E*@=)Y5ZD$X6Z]TW7M!>K]JUS;%BUM
MUY1]$:ZV/3[Z0TII"%9_I(XU?B=6+$63VQ+9:ID>08D1\9%C,M1X$5U[R.2'
M[OF$K@P$8EAMX0TNE:G5H4@..E.GN!0%D)2"$@\5<5$#LK-'6^)(Z?=/\?T>
MVYC,R-DQ<LN=+S$Z#*AHRV77'Y ,)N0V@LP8T9*T14+_ .(D:G9+R&]26F[(
M.1BM3ZK[Z-X^MZ;NKN4==P2*[PV+:Z1JU]Q>7D5?KGI6VGZ#K\ '0YES YFV
MV$27M!##.4IERRZ,KPK##64R3/\ _!)8P;?!$=I*W/\ :>=2%K)\^D%*$W[
MGW36SWB+/_0T?;_03'#DPMNXJ-+R*0+&1G,K&9F37G2+:S&8<C8]G5<MMQE!
M-N8N_7^WQQ\QJ7:(BJ8D9M!375V'5O$1WV$K)^=6B<8/B,]_ZF1\1=;\BO\
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MH6&RC$I;+:DI6XEI6HH2I7=!/D)X537UR]&+9^D>J7=+KP3W70SACM$#UT*
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M:=SL 8SX)=X&J_$=ZZ4#A_2DGC;@;>[66(?BXVW%7T?6</./_;5+PD_"M?\
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M3\"^KRX^\>^_5A_0?UH?4[](?=O=?_B[Z)^_>R_H[S\^&WEI6NF_ZA'DUO\
M2GZR?9_1:K>[?2;^M-Y/JQ^L0E]7?]83XM^9]4GU@^]?1OZPOZ"\GM_</_ >
M\\<*5L-0_P#U_P#UAK\?A/U@>^V_W7ZY_K*]I[O\.5\3^#?7/_1'T6^#>^_
M_=OZ/]T^+?"OT?Q3GSA?W:5KG7K_ /7G]/J)]2/TF^+_ !-/U7?'OZR?U6?2
M_P"I\9_N_P#K-_\ Q#]9/U(^Q_\ 9_\ 3GP3V_E_1^]\^\+TJS3GVE.*4XI3
MBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*
M4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*
+4XI3BE.*4XI7_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
